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In recent years, nanomaterials have demonstrated their potential to enhance the sensitivity and 
utility of biosensors due to their superior electrical and mechanical properties. Specifically, 
carbon-based nanomaterials, such as carbon nanotubes (CNTs) and graphene have proven their 
practicality over other nanomaterials because of their low-cost, wide availability, high surface-to-
volume ratio, and potential biocompatibility, to name a few. These nanomaterials when 
incorporated with biosensing devices are expected to enhance the critical sensing performances of 
the biosensors. Therefore, in this dissertation, these carbon nanomaterials are utilized to build 
nanoelectronic devices for highly sensitive and selective detection of protein biomarkers—
biological molecules expressed in response to diseases like cancer, malaria, AIDS, Alzheimer’s, 
etc. Graphene when used in field-effect transistor (FET) configuration has shown to be effective 
in biosensing. However, such graphene FET (GFET)-based biosensors suffer from several 
drawbacks, limiting their performances and usage. Thus, most of the work in my dissertation 
focuses on the development of graphene FET (GFET)-based biosensors for protein detection as 
well as the enhancement of performances by optimizing electrode design and integrating to 
microfluidics. The novelty of this work lies in the first detection of lysozyme, a model protein 
biomarker, with a limit of detection in the clinically relevant range. Moreover, this GFET platform 
is further advanced by integrating to microfluidics platform where real-time sensing of another 
protein biomarker, namely thrombin, is demonstrated with the lowest limit of detection reported 
so far with GFET.  
 
For selective detection, biosensors are often equipped with a recognition element, 
alternatively known as the bioreceptor. Aptamers were used throughout this work because they 
offer a number of unique properties that make them a suitable candidate with respect to its 
counterparts such as antibodies and enzymes. Sensing performances and applicability of the 
sensors often depend on the proper functionalization of aptamers on the sensing surfaces. 
Therefore, this dissertation also focuses on the development of novel aptamer immobilization 
methods to enhance reproducibility, automation, as well as rapid, easy and mass-scale production. 
Besides GFET-based biosensors, a disposable low-cost electrochemical biosensor was also 
developed for the selective detection of lysozyme protein. The main goal of the project is to explore 




CNTs mixed with aptamers at a certain ratio not only enhances the printability of the ink, but also 
augments the conductivity of the electrode. With this printing-based novel aptamer immobilization 
method, the detection of lysozyme was demonstrated with the sensitivity comparable to other 
conventional methods.  
 
Finally, the flexibility of graphene is exploited to build a flexible GFET envisioned for 
wearable biosensor. To avoid the expensive and sophisticated microfabrication, the electrodes are 
printed with conductive silver ink on a flexible substrate. Kapton®, a polyimide film is chosen 
because of its flexibility, chemical and thermal stability. With this Kapton-based flexible GFET 
sensor, a real-time detection of interleukin-6 (IL-6) protein, a well-known cytokine and a key 
biomarker for various immune responses, was demonstrated for the first time. 
 
In summary, the dissertation provides guidelines and insights for the development of highly 
sensitive nanoelectronic devices envisioned for a low-cost, highly reproducible, rapid, portable, 
and miniaturized biosensor for healthcare monitoring. In particular, this research sheds light on the 
feasibility of using carbon nanotubes (CNTs) and graphene for the exciting new applications in 
















In ancient times, healthcare used to be provided at the patient’s side – doctors used to visit the 
patients with whatever medical diagnostic tools they had to treat their patients (Figure 1.1). But 
with the advent of modern sophisticated and bulky medical instruments, healthcare has transferred 
from the patient’s side to remote hospitals and diagnostic centers (Figure 1.2A). Nowadays, 
patients are required to visit a hospital or a clinic to receive healthcare. However, the situation 
becomes an issue in the developing countries where there is a shortage of enough hospitals and 
clinics as well as lack of proper means of transportation.  
Recently, there has been a concerted effort to bring the healthcare back to the patient’s side, where 
visiting a hospital or a doctor may be less frequent, thanks to the progress in miniaturization and 
portable technology that led to the development of point-of-care (POC) diagnostic devices. One of 
the examples of commercialized POC devices is the glucose sensor (Figure 1.2B) to monitor and 
quantify the sugar level in blood at home.  
Figure 1.1. Healthcare system in ancient times. Doctors used to visit the patients to diagnose their 







Figure 1.2. Transformation towards point-of-care: (A) bulky laboratory setup located at remote 
hospitals and clinics, and (B) the glucose POC device used to monitor and quantify sugar level in 
the blood. 
 
One of the major components of these POC devices is the biosensor. Other applications of 
biosensors are drug delivery, environmental monitoring, soil quality monitoring, food quality 
monitoring, toxins of defense interest, water quality management, and prosthetic devices as 
illustrated in Figure 1.3. Due to the versatile applications of biosensors, the research on biosensors 
has been constantly boosting up, as seen by the exponential increase in the number of publications 





with a keyword ‘biosensor’ as presented in Figure 1.4A. Figure 1.4B shows the global market for 
biosensors that is quite large and is only expected to grow in the coming years as interest in food 
quality, health care monitoring, disease diagnostics, and national security continue to grow.  
 
 
Figure 1.4. Graphs showing (A) the number of publications on the keyword “biosensor” during 
the period 1980 to 2011, and (B) the world market for biosensors estimated from various 
commercial sources. Adapted from [1].  
 
1.2. Thesis Overview 
The purpose of this thesis is to offer insight into the emerging technology in the development of 
biosensors. The focus of the thesis is to explore the field of nanoelectronics and nanoelectronic 
devices to enhance the sensitivity of nanobiosensors as well as to solve issues in conventional 
methods for functionalizing bioreceptors. Nanoelectronics which can simply be defined as the 
electronics of nanomaterials, are particularly important for biosensors because of the versatile 
advantages they incorporate to the sensing systems, such as high selectivity and sensitivity, 
biocompatibility, miniaturization, etc. Among different nanomaterials, carbon nanomaterials such 
as carbon nanotube and graphene provide exciting new opportunities for biosensing applications 
due to their extraordinary electrical and mechanical properties.  
 
In this thesis, CNTs are used to develop an electrochemical biosensor for the detection of lysozyme 
protein which can act as a biomarker for a number of diseases such as breast cancer, Alzheimer’s, 
rheumatoid arthritis, malaria, etc. Herein, we also explore the possibility of using inkjet-printing 





been around for quite some time, but recently it has attracted much attention as a deposition 
technique due to its several advantages such as controllability of deposited ink with great precision, 
rapid and automated printing process at low-cost, printability of multiple materials simultaneously 
as well as easy development of microarrays. Moreover, inkjet-printing is an “additive” 
manufacturing technique as opposed to the “subtractive” manufacturing techniques like 
lithography, that significantly reduces the amount of material wastage.  
 
Upon completion of this inkjet-printed CNT biosensor, another new carbon nanomaterial graphene 
is exploited to develop a field-effect transistor (FET) biosensor which is later integrated to 
microfluidics to extract the combined advantages of graphene and microfluidics, such as high 
sensitivity, flexibility, and compatibility with lab-on-a-chip devices.  
 
The next goal is to push this GFET detection platform further towards flexible electronics to 
develop wearable biosensors, which are non-invasive devices that can be worn or mated with the 
human skin to continuously and closely monitor an individual’s activities without interrupting or 
limiting the user’s daily routine.  To develop this flexible GFET, a flexible substrate is used to 
replace the rigid SiO2/Si substrate. Here, I use Kapton®, a polyimide film as the flexible substrate 
due to the advantages it offers. To avoid the high cost and complexity in microfabrication, 
electrodes are formed by simply printing commercially available conductive silver ink on the 
flexible substrate.  
 
1.3. Thesis Outline 
This thesis presents the development and application of nanoelectronic devices for biosensing 
specially protein sensing. A major part of this thesis focuses on the development and application 
of GFET devices for detection of protein biomarkers. Apart from GFET-based biosensing, a novel 
inkjet-printed electrochemical biosensor is developed and applied for sensing of protein. To 
accommodate them along with the theoretical background, the thesis is divided into nine chapters. 
 
Chapter 2 provides the theoretical background of biosensors—definition, history and evolution, 
and classification of biosensors of particular interest. A brief introduction to aptamers as 





background for carbon-based nanoelectronics, especially the electronics of two popular carbon 
nanomaterials, namely CNT and graphene.  
  
Chapter 4 describes the development of the novel inkjet-printed biosensor. The chapter presents 
the detailed protocol for the CNT-aptamer ink preparation, characterization and measurements as 
well as discusses the results. 
 
Chapter 5, 6 and 7 are built on the development and application of GFET-based sensors. 
Specifically, Chapter 5 describes the first detection of lysozyme protein with a nanomolar limit of 
detection. Chapter 6 further advances this GFET platform by integrating with microfluidics and 
demonstrates the sensing of another protein thrombin with picomolar limit of detection—lowest 
among the other GFET-based thrombin sensors reported so far. Chapter 7 discusses the extension 
of this rigid GFET to a flexible platform and presents the development of this flexible GFET on a 
polyimide film along with the demonstration of the real-time detection of a sweat-based protein, 
namely interleukin-6 (IL-6).  
 
Chapter 8 presents a novel aptamer immobilization method on GFET platform where 
commercially available amine-linked aptamers are preconjugated with pyrene group and this 
pyrene tagged aptamers, soluble in water-based solvents, are exposed to GFETs. This chapter 
discusses the detailed process and characterization of the preconjugation as well as the 
measurement results showing the sensing of IL-6 protein as a representative analyte.  
 













CHAPTER 2: FUNDAMENTALS OF BIOSENSORS 
 
2.1. What is a Biosensor?  
According to the definition of International Union for Pure and Applied Chemistry (IUPAC), a 
biosensor is a self-contained integrated device which is capable of providing specific quantitative 
or semi-quantitative analytical instrumentation using a biological recognition element 
(biochemical receptor) in direct spatial contact with a transducer element [1].  It can simply be 
viewed as a device that converts a physical or biological event into a measurable signal. As can be 
seen in Figure 2.1, it consists of three main parts: (1) a biorecognition molecule or a bioreceptor 
(aptamer, tissue, microorganism, organelle, cell receptors, enzyme, antibody, protein, etc.) which 
is a biologically derived material or biomimetic component that provides selectivity to the target 
analyte, (2) a transducer (physicochemical, optical, piezoelectric, electrochemical, etc.)  that 
converts the resulting signal from the interaction of the analyte to the biosensing element into a 
measurable and quantifiable signal (in most cases electrical signal), and (3) the associated 
electronics or data analysis system which is primarily responsible for signal processing and user-
friendly visualization of the sensing results.  
 
 
Figure 2.1. Schematic illustration showing different parts of a biosensor: (a) biorecognition 





There are several classes of bioreceptors with distinct structures that uniquely affect the biosensor 
performance. These numerous bioreceptors can be categorized into two main types -- natural and 
synthetic. Natural bioreceptors, such as antibodies and enzymes, are biologically derived 
constructs that take advantage of naturally evolved physiological interactions to achieve analyte 
specificity. On the other hand, synthetic bioreceptors, such as aptamers and molecularly imprinted 
polymers (MIPs) are artificially engineered structures developed to mimic physiologically defined 
interactions [3].  
   
2.2. History and Evolution of Biosensors  
The history of biosensors dates back to the 1950s, when Leland Clark Jr. invented the first and 
foremost electrochemical oxygen biosensor in 1956. Known as the Clark oxygen electrode, it 
consisted of a sliver/silver chloride reference electrode and a platinum cathode at which oxygen 
was reduced [4]. This oxygen electrode was later combined by Clark and Lyons with glucose 
oxidase incorporated in a dialysis membrane to measure the concentration of glucose in solution 
[5].  A couple of years later in 1967, Updike and Hicks described the first “enzyme electrode” for 
in vitro quantification of glucose in solution and in tissues. The electrode was engineered through 
immobilization of glucose oxidase in a polymerized gelatinous membrane that coated a 
polarographic oxygen electrode, thus serving as an enzyme transducer to catalyze an 
electrochemical reaction upon recognition of glucose [5].  
 
Later in 1969, the first potentiometric enzyme electrode was developed by Guilbault and Montalvo 
to realize a urea sensor based on the immobilization of urease onto an ammonium-selective liquid 
membrane electrode [6]. Since then, a broad range of biosensors have been developed for in vitro 
and in vivo applications, whose nature ranges from enzymatic, to antibody, polypeptide, aptamer, 
or nucleic acids-based. Similarly, the evolution of a variety of transduction mechanisms has 
diversified the field of biosensors, ranging from electrochemical and electronic biosensors to 
thermic biosensors that measure the changes in temperature associated with the amount of heat 
generated by an enzyme-catalyzed reaction; microbial biosensors which integrate micro-
organisms with a physical transducer, such as an electrochemical device, to monitor specific 
analytes or biomarkers typically through the production of electroactive metabolites; 





fragments; optical biosensors, based on the differences in optical diffraction or changes in the 
emission of light signals upon target binding. The field is now a multidisciplinary area of research 
that bridges the principles of basic sciences (physics, chemistry, and biology) with fundamentals 
of micro/nanotechnology, electronics, and applicatory medicine [7], [8].  Figure 2.2 shows the 
timeline for biosensors development until 2010.  
 
Figure 2.2. History and evolution of biosensors over time. Reproduced from [7]. 
 
2.3. Aptamers as Biorecognition Elements 
Derived from the Latin word aptus meaning “to fit”, aptamers are often used as one of the most 
trending biorecognition elements. First reported in 1990, aptamers recognize specific ligands and 
bind to various target molecules from small ions to large proteins with high affinity and specificity 
[9]. Aptamers are single-stranded oligonucleotides designed through a combinatorial selection 
process called Systematic Evolution of Ligands by Exponential Enrichment (SELEX). As shown 
in Figure 2.3, SELEX is an iterative process to search a library of randomly generated 
oligonucleotide sequences (1015 – 1018) for strong binding affinities between the target analyte and 





incubation of the target bioanalyte with an oligonucleotide library containing all potential aptamer 
sequences. Unbound aptamer sequences are washed away, and the bound aptamers are collected 
and go through polymerase chain reaction (PCR) amplification to regenerate the oligonucleotide 
library for the next SELEX round [3].  
  
 
Figure 2.3. Schematic illustration of aptamer production by Systematic Evolution of Ligands by 
Exponential Enrichment (SELEX) process. Reproduced from [3]. 
 
Typically, around 30 – 100 nucleotides long aptamers possess high chemical stability, mass-
producibility and reusability, longer shelf life, low production cost, small size and no batch-to-
batch variations making them superior to their counterparts like antibodies, enzymes, proteins, etc. 
Moreover, aptamers undergo conformation change when they specifically interact with their 
targets, thus omitting the need for additional labeling process during monitoring of target binding 
events [10]. Due to these advantages, aptamers are often used as an integral part of biosensors 
leading to the creation of new research field called aptasensors. Due to their versatile potential 






2.4. Sensing of Protein Biomarkers  
A biomarker is a biological characteristic that is objectively measured and evaluated as indicators 
of normal biological processes, pathogenic processes or pharmacological responses to a 
therapeutic intervention [11]. They can be used to determine disease onset, manifestation, 
progression, efficacy of drug treatment, and patient’s susceptibility to develop a certain type of 
disease [12]. Among all biomarkers, proteins represent the most studied molecules because of (1) 
their direct association with the disease state [13] as well as (2) the availability of a large range of 
analytical instrumentation to identify and quantify proteins in complex biological samples, such 
as blood, saliva, etc. [14]. It is also possible to generate aptamers for almost every protein target, 
which make protein biomarkers a convenient target for aptamer-based biosensors. The high 
structural complexity of proteins allows them to bind with aptamer binding by stacking 
interactions, shape complementarity, electrostatic interactions, and hydrogen bonding. Moreover, 
in principle, proteins can present more than one binding site for aptamers, allowing the selection 
of a pair of aptamers binding to different regions of the target and enabling sandwich-assay based 
biosensors [15]. Hundreds of protein biomarkers have already been discovered for different 
diseases such as, cancer, Alzheimer’s, AIDS, rheumatoid arthritis, malaria, tuberculosis, leprosy, 
sarcoidosis, Crohn’s and cardiovascular diseases so far and researches are being done to discover 
more protein biomarkers, which is one of the goal of the research field proteomics.   
  
2.5. Classification of Biosensors  
As mentioned earlier, biosensors can be classified into different types depending on the detection 







Figure 2.4. Schematic illustration showing the types of biosensors based on different detection 
principles. 
 
2.5.1. Optical biosensor  
Optical detection is one of the most commonly used popular detection principles because it offers 
multiple advantages, such as direct, real-time, and highly sensitive detection of many biological 
and chemical substances. Optical detection works by exploiting the interaction of the optical field 
with a biorecognition element to produce an electrical signal which is proportional to the 
concentration of the analyte. The signal can be either absorbance, fluorescence, 
chemiluminescence, colorimetry, interferometry, or surface plasmon resonance.  
 
Among different optical detection mechanisms, fluorescence-based detection is by far the most 
widely used sensing technique. Fluorescence-based techniques work on the basis of the Förster 
resonance energy transfer (FRET) which involves the coupling of a fluorescent molecule that emits 
visible light (fluorophore) to another fluorescent molecule that absorbs visible light and emits at 
invisible wavelengths (quencher).  Figure 2.5 shows the mechanism for FRET-based optical 
biosensor used by Weng and Neethirajan who utilized quantum dots-aptamer–GO complexes 
(QDs-aptamer-GO) as probes for sensitive detection of food allergens [16]. This device utilized 





change upon interaction with the food allergens. In the absence of the target analyte, the 
fluorescence of the QDs is quenched via FRET process between the QDs-aptamer probes and GO 
due to their self-assembly through specific π-π stacking interaction, resulting in no fluorescence 
signal. Upon binding with the target analyte, due to conformational change of the aptamers, QDs-
aptamer probes are released from the GO leading to the recovery of fluorescence of QDs. 
 
Figure 2.5. Schematic diagram showing the FRET-based sensing mechanism.  Reprinted from 
[16].  
 
Though optical biosensors exhibit high sensitivity, often they require labels such as methylene 
blue, fluorophore, etc. requiring complex chemistry for attaching the labels to the recognition 
elements. Also, optical biosensors are bulky, and require sophisticated laboratory setup along with 
trained technicians, thus increasing the overall cost of the sensor setup.  
 
2.5.2. Electrochemical biosensor 
Electrochemical biosensors provide an attractive means to analyze the content of a biological 
sample due to the conversion of a biological event to an electrical signal. For example, the reaction 
under investigation generates a measurable current (amperometric/voltammetric), a measurable 
potential or charge accumulation (potentiometric), or alters the electrical conductivity between 
electrodes. Electrochemical impedance spectroscopy (EIS), or impedimetric sensing, is also a 
commonly used technique where a biological or chemical event causes a change in the impedance 







Figure 2.6. Electrochemical biosensor: (A) target-induced conformation change of aptamer; and 
(B) voltammogram as the sensor responds to 64 nM thrombin in 50% blood serum. Adapted from 
[18].  
 
Amperometric detection is the first electrochemical technique adopted in microscale [19]. 
Amperometric biosensors are those devices that transduce the biological recognition events caused 
by the oxidation or reduction of an electroactive biological species at the sensing surface into an 
electrical signal for the quantification of an analyte within a sample matrix. The intrinsic simplicity 
of the transducer lends itself to low-cost portable devices for applications ranging from disease 
diagnosis to environmental monitoring [20]. On the other hand, a voltammetric sensing is a 
technique where the electrical potential at the working electrode is scanned from one preset value 
to another, and the cell current is recorded as a function of the applied potential [21]. One of the 
pioneers of electrochemical biosensor is Professor Kevin Plaxco from the University of California, 
Santa Barbara (UCSB) who exploited the target-induced conformation change of aptamers to 
develop an aptasensor for sensitive detection of thrombin [18] as schematically illustrated in Figure 
2.6.  
 
Unlike amperometric technique, this voltametric technique monitors the redox activity across a 
range of applied potentials manifesting well-defined current peaks [22]. Voltammetry has been 
practiced for a long time and has revolutionized analytical chemistry. The main advantages of 






precision, accuracy and cost effectiveness. In the past, voltametric techniques were difficult to 
apply without computer controlled potential scan and were not nearly as useful as they are today. 
However, in present days, these techniques are largely available due to the advent of computers 
and their key role in the control and measurement of the potentials and currents of potentiostats 
[21].  
 
Another popular electrochemical detection mechanism is the label-free impedimetric technique 
which works by measuring the impedance of the electrode/electrolyte interface over a wide range 
of frequencies. The resulting spectrum is called the electrochemical impedance spectrum (EIS) 
that can be used to monitor the changes in the electrical properties of the biosensor at different 
stages, including different fabrication steps as well as the detection of target recognition events. It 
offers several unique advantages that include the ease of signal quantification, the ability to 
separate the surface binding events from the solution impedance, non-invasive measurement, real-
time monitoring, and label-free detection, making it an effective tool for electrochemical 
interrogation [23]. EIS can analyze both the resistive and capacitive properties of the electrode 
surface upon excitation/perturbation of the system at equilibrium by a small amplitude sinusoidal 
excitation signal [24]. One of the common representation of the EIS is the Nyquist plot (Figure 
2.7A), that can be modeled by the Randles circuit as seen in Figure 2.7B. It consists of a solution 
resistance (RS), a double-layer capacitance (Cdl), a charge transfer resistance (Rct), and the Warburg 
impedance (ZW).  RS is inserted as a series element because all the current passes through the 
uncompensated solution, while the parallel elements are introduced because the total current 
through the electrode is the sum of distinct contribution from the Faradic process and the double-
layer capacitance charging.   
 





Cdl and Rct are often used as the detection parameters in biosensing as they represent the dielectric 
and insulating features at the electrode/electrolyte interface, while RS and ZW depend on the bulk 
properties of the electrolyte and the diffusion of the redox probe, respectively [25]. For example, 
Chen et al. employed the change of Rct to implement a label-free impedimetric biosensor for highly 
sensitive detection of lysozyme protein [26].  Lysozyme binding aptamer was modified on a gold  
 
Figure 2.8. Label-free impedimetric biosensors based on electrochemical impedance spectroscopy: 
(A) working principle; and (B) EIS measurements for different concentrations of lysozyme. 
 
electrode and EIS measurements were performed in [Fe (CN)6]
4−/3−redox couple. As seen in Figure 
2.8A, binding of lysozyme to aptamer blocks the path for charge transfer from the redox couple to 
the electrode, effectively increasing the charge transfer resistance Rct which is reflected in Figure 
2.8B. Due to the huge promise EIS offers, we have designed and implemented an impedimetric 
biosensor for selective detection of lysozyme protein that is presented in Chapter 3.  
 
2.5.3. Field-effect transistor biosensor  
Field-effect transistors (FETs) have attracted much attention in the biosensing community as they 
offer many advantages such as ease of miniaturization, low-cost, large-scale integration capability 
with the existing manufacturing process as well as label-free, rapid, and highly sensitive detection 
of analytes [27]. A typical FET biosensor is composed of a semiconducting channel that connects 
the source and the drain electrodes. Upon adsorption of the biomolecules on the channel surface, 
a change in the electric field occurs which affects the gate potential of the device resulting in a 





can be conveniently measured and be utilized as an interrogation strategy to probe the adsorbed 
biomolecules.  
 
This type of sensing mechanism has been demonstrated in the past for detecting target analytes in 
various media including gases, aqueous liquid, as well as in human serum [27]–[32].  For example,  
 
Figure 2.9. Schematic representation of the working principle of FET biosensor: (A) Device 
structure of the electrolyte-gated graphene FET biosensor. (B) Time course of ID for the biosensor. 
At 10-min intervals, various concentrations of IgE were injected. Reproduced from [32].  
 
Ohno et al. demonstrated a label-free immunosensing of IgE protein using an aptamer-modified 
graphene FETs (Figure 12A) [32]. The aptamer-modified graphene FETs showed selective 
electrical detection of IgE protein. From the dependence of the drain current variation on the IgE 
concentration, they also estimated the dissociation to be 47 nM, indicating good affinity (Figure 
2.9).  
 
2.5.4. Mass sensitive biosensor 
Gravimetric or mass sensitive biosensors work on the basic principle of measuring the change in 
the mass at the sensing surface caused by the binding of the analyte to the receptors. Most mass 
sensitive biosensors use piezoelectric quartz crystals which can be either in the form of resonating 
crystals (such as quartz crystal microbalance, QCM) or surface acoustic wave (SAW) devices [33]. 





toxins [35] because of their multifarious advantages such as ease of use, shorter analysis time, low-
cost, as well as the possibility of label-free and real-time detection. On the other hand, SAW-based 
biosensors can detect acoustic waves generated by the interdigital transducers (IDTs) which are 
periodic metallic bars deposited on a piezoelectric material. Upon recognition of an analyte by the 
immobilized receptors, the velocity of the SAW changes that produces signal by the driving 
electronics. Figure 2.10 shows the operating principle of a QCM-based mass sensitive biosensor  
 
 
Figure 2.10. Operating principle of a QCM-based mass sensitive biosensor. When any analyte 
binds to the selective receptor, a change in the mass loading occurs that can be detected by a change 
in the frequency. Reproduced from [36].  
 
for virus recognition. The change in mass in response to virus binding with the selective receptor 
is detected as a change in frequency of QCM transducer. 
 
2.6. Summary 
The following table (Table 2.1) summarizes the advantages and disadvantages of the four 
detection techniques described above.  
 
Table 2.1. Advantages and disadvantages of different detection techniques [33]. 
 





Optical High sensitivity, remote controllable  Often requires labels, costly, 
fragile, and bulky setup  
Electrochemical Good resolution, excellent accuracy, 
repeatability  
Susceptible to temperature 
changing, short shelf-life 
FET based Highly sensitive, faster response, 
mass producible, label-free 
Not suitable for receptors longer 
than the Debye length 
Mass sensitive Highly sensitive, suitable for target 
molecules that don’t have 
electrically conducting property or 
optical signal (e.g. virus)  
Fragile and mechanically unstable 
 
In this thesis, we developed two types of biosensors, namely the impedimetric and the GFET-
based, for selective detection of protein biomarkers.  
 
2.7. Conclusion 
In this chapter, I describe the basics of biosensors—definition, working principle, history, and 
evolution. A brief introduction of aptamers as recognition elements and proteins as target 
biomarkers is also presented. In addition, I present different types of biosensors, namely optical 
biosensor, electrochemical biosensor, field-effect transistor biosensor, and mass sensitive 
biosensor. In particular, their working principle, state-of-the-art development as well as the 
challenges are delineated. Finally, their comparative advantages and disadvantages are 













 CARBON-BASED NANOTECHNOLOGY 
FOR BIOSENSING 
3.1. Introduction  
Modern technology is characterized by its emphasis on miniaturization, a trend to manufacture 
ever smaller mechanical, optical and electronic products and devices. For example, in the IC 
industry, remarkable technological progress has occurred in terms of reductions in the size of 
transistors, thus increasing the number of transistors per chip. This trend, which is known as the 
Moore’s law (Figure 3.1), states that the number of transistors in an IC doubles about every two 
years [37]. This trend of miniaturization has evolved in time and taken us to the nanometric regime, 
leading to the term “nanoelectronics”.  Essentially, nanoelectronics is the application of  
 
 
Figure 3.1. The number of transistors in the CPU as a function of time. The trend shows a doubling 





nanotechnology1 for electronic components and aims at improving the capabilities of electronics 
such as display, size, and power consumption of the device for everyday use [38]. It is based on 
the quantum mechanical properties of the hybrid material, semiconductor, one dimensional (1D) 
materials such as nanotubes, 2D materials such as graphene, and so forth. The integration of 
nanoelectronics and nanoelectronic devices with biosensors leading to the term nanobiosensors 
has become very popular due to different advantages it offers to the sensor. These advantages are 
achieved by using different nanomaterials as the biosensing interface and nanodevices as the 
transducers.  
.  
Figure 3.2. Nanoscale showing the dimension range for nanomaterials. Reproduced from [39]. 
 
Nanomaterials are materials with minimum one dimension in the nanoscale (Figure 3.2). In this 
scale, nanomaterials possess unique properties that play significant role in the development of 
 
 
1 According to the National Nanotechnology Initiative (NNI), nanotechnology is the understanding 
and control of matter at dimensions between approximately 1 and 100 nm, where unique 






biosensors. This significance arises from the fact that nanomaterials can help address some key 
issues in designing biosensors. Such issues include: (1) design of the biosensing interface so that 
the analyte selectively interacts with the biosensing surface; (2) achievement of efficient 
transduction of the biorecognition event; (3) increase in the sensitivity and selectivity of the 
biosensors; and (4) improvement of response times in highly sensitive systems [40]. More 
specifically, nanomaterials make biosensors compatible with biological matrices so that they can 
be used in complex biological samples or even in vivo; enable fabrication of viable biosensors that 
operate within confined environments such as inside cells; and simultaneous detection of multiple 
biosensors in one device. Nanomaterials can be classified as zero-, one-, and two -dimensional 
systems. This includes semiconductor quantum dots, metallic nanoparticles, metallic or 
semiconductor nanowires or nanotubes, nanostructured conductive polymers or nanocomposites, 
mesoporous materials, etc. Among them carbon-based nanostructures are the most popular because 
of their low-cost, wide-availability, potential biocompatibility, etc.  
 
The electronic configuration of carbon in ground state is 1s22s22p2. But in excited state, carbon 
can exist in three different states corresponding to sp3-, sp2-, and sp- hybridization of their valence 
orbitals leading to the formation of different carbon allotropes. These allotropes enable the 
formation of different types of carbon nanomaterials such as CNTs, graphene, carbon dots, carbon 
nanofibers, nanodiamonds, and buckminsterfullerene as seen in Figure 3.3. The following section 
will discuss the fundamentals of carbon nanoelectronics with respect to carbon nanotubes and 
graphene.   
 
 





3.2. Carbon Nanoelectronics  
The field of carbon nanoelectronics has grown significantly with rapid developments in device 
performances and high yield assembly of single-walled carbon nanotubes (SWCNT) and 
graphene-based devices. Such a rapid growth is largely fueled by the unique single-atomic layer 
honey-comb structure of these carbon allotropes, that leads to many extraordinary physical 
properties such as extremely high electron and hole mobilities (potentially in excess of 100,000 
cm2/V/s), extremely high strength (greater than steel), along with other extreme properties [42], 
[43]. In this section, the electronics of these carbon nanomaterials, CNTs and graphene in 
particular, will be discussed.  
 
3.2.1. Carbon nanotubes (CNTs)  
To date, arguably the most widely studied one-dimensional (1D) material in nanoelectronics is the 
carbon nanotube. CNTs are well-ordered, graphitic sheet rolled up into a hollow cylinder of sp2-
hybridized carbon atoms [40]. They can be classified into two categories – single-walled carbon 
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs). Though SWCNTs and 
MWCNTs are similar in certain aspects, they have some striking differences. Structurally, 
SWCNTs are single sheets of graphene rolled into cylinders, MWCNTs are composed of several 
concentric tubes (approx. 6 – 25) that share the same longitudinal axis. As 1D carbon allotropes, 
CNTs have lengths that can range from several hundred nanometers to several millimeters, but 
their diameter depends on their types: for MWCNTs, the outer diameter is typically 30 – 50 nm 
and for SWCNTs, it is typically 0.7 – 2.0 nm [44].  
 
Among different electronic properties, the conductivity of the CNTs is especially critical for their 
role as nanomaterials in electrochemistry. While MWCNTs are regarded as metallic—a highly 
attractive property for an electrode, the electronic properties of SWCNTs are controlled by the 
chiral vector, that connects the centers of two hexagons. The chiral vector is given by 𝐶 = 𝑛𝑎1 +
𝑚𝑎2 (Figure 3.4), where 𝑎1 and 𝑎2 are the unit vectors of the graphene lattice, and the pair of 
integers (n, m) is called the chiral index or just chirality. Depending on the chirality, SWCNTs can 
be either metallic if (n-m) is multiple of 3; or semiconducting otherwise [40]. Thus, with small 
diameter SWCNTs approximately two-thirds are semiconducting, and one-third are metallic. 





gap semiconductor. Therefore, the varieties of conductivities in a mixture of SWCNTs can 
complicate their applications in electrochemistry compared to MWCNTs.   
 
 
Figure 3.4. Chirality in SWCNTs. A chiral vector C can be defined by a chiral index (n, m) using 
the basis vectors a1 and a2 of a graphene sheet. Reproduced from [45]. 
 
 
CNTs can be produced by different methods such as chemical vapor deposition (CVD), laser 
ablation and arc discharge [46]. The resulting product not only contains the CNTs, but also 
contains the catalyst particles and amorphous carbons as impurities. In addition, the CNTs are not 
identical in length and chirality. This is one reason why the large-scale manufacturing of identical 
CNT devices still remains a challenge [47].  
 
Electrochemically, CNTs are not very reactive due to their highly graphitized nature. But there is 
evidence that favorable electrochemical properties of SWCNTs can be achieved from oxygenated 
carbon species, especially carboxyl moieties that are produced on the tips of the nanotubes during 
acid purification [48], [49]. This is in contrast to the MWCNTs that experience slow rate of 
heterogeneous electron transfer if functionalized with oxygen-containing groups [50], [51]. 
According to Pumera et al., the oxygen-containing groups in fact play a minor role in the 
heterogeneous electron transfer for electrochemically activated MWCNTs [52]. Rather, they 
suggest that the increased heterogeneous electron transfer is due to an increase of the density of 






The electrochemical behavior of CNTs was explored by several groups to design and implement 
aptamer-based biosensors [53], [54]. For example, Rohrbach et al. have implemented a label-free 
impedimetric aptasensor for selective detection of lysozyme using MWCNTs [54].  The working 
electrode was modified with MWCNTs which was deposited by simple pipetting of carboxylated 
(5%) MWCNT suspension. In the following step, aminated anti-lysozyme aptamers were 
immobilized on the working electrode via the covalent linkage between the carboxylic groups of 
the nanotubes and the amino groups of the aptamers (Figure 3.5A).  When any lysozyme binding 
occurs, the net positive charge of the aptamer-lysozyme interaction enhances the charge transfer 
from the redox couple to the working electrode, thereby decreasing the charge-transfer resistance, 
Rct (Figure 3.5B). By monitoring the change in Rct, they were able to detect lysozyme with a 
detection limit of 862 nM.  
 
 
Figure 3.5. Impedimetric biosensor for label-free detection of lysozyme using MWCNTs: (A) 
modification of the working electrode with MWCNTs; and (B) electrochemical impedance 
spectroscopy measurements for different concentrations of lysozyme and the corresponding 
calibration curve. Reproduced from [54]. 
 
 
The sidewalls of the nanotubes being very hydrophobic, dispersion and manipulation of CNTs in 





Moreover, their tendency to aggregate and form clusters owing to high van-der-Waals force 
between the tubes limit their dispersibility in aqueous or polar solvents [48], [55]. As a 
consequence, dispersing tubes is usually performed in non-polar organic solvents such as dimethyl 
formamide (DMF), N-Methyl-2-pyrrolidone (NMP), tetrahydrofuran (THF) or with the aid of 
surfactants, polymers such as nucleic acids or oxygenated functional groups such as carboxylic 
acids [48], [53], [56]. Figure 3.6 illustrates the nucleic acid-assisted dispersion of CNTs where 
single-stranded DNA (ssDNA) helically wraps the CNT using the π – π stacking internactions 
between the nucleotide base of the ssDNA and the CNT sidewall, thus converting it into a water-
soluble object [57]. Several research groups have used this nucleic acid-assisted dispersion of 
CNTs to implement nucleic acid aptamer-based biosensors [58], [59]. For example, Lian et al. has 
developed a piezoelectric aptamer biosensor on interdigital electrode (IDE) for selective detection 
of lysozyme protein [59]. The IDE was modified with aptamer-wrapped-SWCNTs which was 
connected to the oscillator circuit in series with the piezoelectric quartz crystal (SPQC).  In the 
presence of target lysozyme, the SWCNTs, being substituted by the lysozyme with greater affinity 
towards the aptamer than the SWCNTs, came off from the IDE surface causing a frequency change 
of the SPQC-IDE. 
 
 
Figure 3.6. Nucleic acid-assisted dispersion of CNT where DNA wraps the CNT helically making 






There are several deposition methods of carbon nanotubes experimented by many groups, such as 
the dip coating [60], spray coating [61]–[63], electrophoretic deposition [64], printing [65]–[68] 
and others. Among them, printing is one of the prominent methods of interest today. Specially, 
inkjet-printing offers several unique advantages such as low cost, rapid printing, easy formation 
of microarrays, automation, easy patterning control and mass-producibility [56]. Inkjet-printing is 
currently being used to deposit various types of conductive nanomaterials such as gold and silver.  
Although these metals are excellent conductors, carbon nanotube-based inks are becoming very 
popular because of their lower cost and more versatile properties in the sense that they can behave 
both as a semiconductor and a conductor. In this thesis, the possibility of employing inkjet-printing 
of CNTs was explored for implementing electrochemical detection of protein biomarkers. 
Aptamers are used as the receptors that simultaneous act as one the dispersing agents for the CNTs 
for preparing the ink for the ink-jet printer.   
 
3.2.2. Graphene  
Known as the world’s first 2D material, graphene has revolutionized the field of biosensing due to 
its many advantages that make it compatible with biosensing platforms. It was first isolated and 
characterized in 2004 by two researchers: Andre Geim and Kostia Novoselov of the University of 
Manchester, bringing them the Nobel prize in physics in 2010 [69].  With a thickness of single 
atomic layer, graphene is isolated from graphite that can be considered as a stacked pile of multiple 
graphene layers held together by van-der-Waals forces. It is the thinnest known material with a 
thickness of 0.35 nm and is composed of 𝑠𝑝2 -bonded carbon atoms arranged in hexagonal network 
[70]. Though incredibly flexible, it is the strongest ever measured material that demonstrates 
excellent conductivity to electricity (better conductivity than copper) and shows unique 
morphological properties.  
 
Graphene can be produced by different methods such as mechanical exfoliation, chemical vapor 
deposition (CVD), etc. The first demonstrated process used by Geim and Novoselov to derive 
graphene was exfoliation of graphite by using a simple scotch tape technique [71]. While 
mechanical exfoliation is a reliable method for producing high quality defect free graphene, it 
produces only a few micrometer-sized sheet and the process being time consuming, not suitable 





method of producing high quality graphene in large scale. A typical CVD process for graphene is 
performed under vacuum and uses heated substrate to break apart the atoms in a gaseous 
hydrocarbon such as methane. The remaining carbon atoms then align themselves atop the 
substrate in the distinctive hexagonal structure of graphene. The graphene film can then be 
transferred to the desired substrate through various techniques. A disadvantage of the CVD process 
is that the growth and transfer process can produce defects in the graphene lattice. Perfecting the 
CVD process is an ongoing goal and is necessary for the commercialization of the many useful 
applications of graphene. 
 
In the past decades, graphene has been experiencing unparalleled usage in the material world and 
has recently gained significant attention in the field of electrochemical and FET sensors thanks to 
its ability to be integrated with different nanomaterials, such as metals, metal oxides, and quantum 
dots [72], [73]. The biocompatibility of graphene in biosensing generates from the combination of 
its versatile properties, such as, enhanced specific surface area, electrical conductivity, chemical 
stability, ease of manipulation, integration-capabilities with different nanomaterials, high 
sensitivity to biomolecules as well as good adsorption capability [70]. The theoretical specific 
surface area of graphene is 2630 m2/g [74] which is approximately twice the specific surface area 
of CNT that ranges from 50 – 1315 m2/g [75]. With such excellent physical properties, graphene 
can even achieve the detection of single molecule making it a promising candidate for biosensing. 
Another property that makes graphene suitable for biosensing is its ease of functionalization. 
Graphene surface can easily be modified with a variety of chemical groups or biomolecules, thanks 
to its hydrophobicity in nature and the tendency to form agglomerates in most of the solvents due 
to van-der-Waals forces [70].  
 
Many of the graphene’s excellent electronic properties originate from its unique band structure 
that exhibits the degeneration of the valence and conduction band at the Dirac point.  
The degeneration at the Dirac point indicates that graphene has a zero bandgap that can be 
modulated by physical or chemical surface modifications. Also in the hexagonal honeycomb 
lattice, each carbon atom with its three 𝑠𝑝2-hybridized planar orbitals forms a strong sigma bond  
(Figure 3.7) with three neighboring carbon atoms resulting in a strong graphene structure that 





[70], [76]. On the other hand, the delocalized electrons in the π bonds above and below the basal 
plane contributes to the high electrical conductivities and mobilities: the room-temperature 
mobility has been measured at 15,000 cm2V-1s-1 while a clean, suspended single layer graphene 
has achieved 230,000 cm2V-1s-1 at temperatures near absolute zero.  This high carrier mobility 
makes graphene a suitable candidate for biosensing with excellent sensitivity as even a single 
biomolecule that comes into contact with its surface can module these properties either by n- or p-
type doping, surface charge induced gating or by Shottkey-barrier modification [40], [70].  
 
As a transducer material, graphene has been investigated by many research groups. For example, 
Lu et al. have implemented a sensing platform for selective detection of DNA and proteins using 
graphene oxide [77]. Chang et al. have developed a graphene-based fluorescence resonance energy 
transfer (FRET) biosensor for sensitive detection of thrombin with a detection limit as low as 31.3 
pM which is two orders of magnitude lower than CNT based fluorescence sensors [78]. Others 
have incorporated graphene into a field-effect transistors (FETs) for detection of various target 







Figure 3.7. Electronic properties of graphene: (A) lattice structure; (B) sp2 hybridization; (C) 3D 
band structure; and (D) the approximation of the low-energy band-structure as two cones touching 
at a single point called Dirac point (bottom). Adapted from [70]. 
 
3.2.2.1. Graphene FET (GFET) as an emerging nanoelectronic device 
A field-effect transistor (FET) is an electronic device which is capable of modulating the current 
through a semiconducting channel by the application of an electric field. In a GFET, graphene is 
used as the semiconducting channel between two metal electrodes: source and the drain that lie 
atop an electrical insulator such as SiO2 (Figure 3.8A). Whenever any charged molecule comes in 
contact with the graphene film, it causes a measurable change in the channel conductance leading 








Figure 3.8. Schematic illustration of the (A) device structure of a graphene filed-effect transistor 
(back-gated); and (B) ambipolar transfer characteristics of the GFET device showing regions for 
hole and electron conduction. 
 
Due to zero-bandgap structure of graphene, carriers (electrons and holes) can be converted to each 
other at the Dirac point resulting in the formation of ambipolar transfer characteristics as shown in 
Figure 3.8B. In the absence of any doping, the gate voltage at the minimum current is the charge 
neutrality point, VCNP, usually referred to as the Dirac voltage, VDirac., which corresponds to having 
the Fermi level at the Dirac point (Intrinsic Fermi level). For VGS> VDirac the Fermi level is in the 
conduction band and the channel current is due to the electron conduction, while for  VGS<  VDirac 
the Fermi level is in the valence band and the channel current is due to the hole conduction. With 
VGS near VDirac, there are a few of either type of carriers and the conductivity of graphene is 
minimum. However, the non-zero current here is due to the thermal distribution of carriers as well 
as spatial fluctuations in energy of the Dirac point [84].  Any adsorbed charged molecule on 
graphene channel surface can induce a horizontal shift to the Dirac point, which can be used as an 
additional sensing mechanism.   
 
3.2.2.2. Electrolyte-Gated GFET (EGFET) 
To apply a GFET to the in-vitro real-time biosensing, the graphene channel must be in exposed to 
the sample solution. This can effectively be done by replacing the insulating material covering the 





device [85]. An EGFET is schematically illustrated in Figure 3.9A. There are several advantages 
of EGFETs compared to conventional GFETs discussed above. The advantages are listed below 
[85]–[87]: 
 
• Low operating potential (<1V) preventing undesired redox reaction or even water splitting 
enabling sensing of biomolecules in aqueous environment. 
• Very stable performance and high transconductance.  
• Low noise operation. 
• Enables real-time measurement.  
 
In an EGFET, the semiconductor channel and the gate electrode are in direct contact with the 
electrolyte, forming two electrical double layer (EDL) capacitors (CG1 and CG2) in series (Figure 
3.9B), equivalently known as the geometrical capacitance, CG. The total capacitance can be 












Where CQ is the quantum capacitance of graphene is related to the Fermi level shift and hence the 
potential drop across this capacitance controls the Fermi level shift. Each of the geometrical 
capacitance can be modeled as a parallel plate capacitor with a plate distance d, which is equal to 







Figure 3.9. Electrolyte-gated graphene field effect transistor: (A) Schematic illustration; and (B) 
the electrical double layer capacitors formed at the graphene-solution and gate electrode-solution 
interfaces. 
 
To fully describe the graphene FET-based sensing mechanism, two major effects caused by the 
presence of charged molecules on the graphene film must be considered; that is the electrostatic 
gating effect and the charge transfer doping effect. These two effects impose opposing actions on 
the sensing mechanisms. The actual sensing mechanism may be determined by the combination of 
these two mechanisms.  
 
The electrostatic gating effect dominates when the concentration of the adsorbed charged molecule 
is high so that the inter-molecular distance is less than the Debye length and the adsorbed 
molecules behave as one of the two plates of the electric double layer (EDL) formed on the 
graphene-electrolyte interface. Now, any additional charged molecule adsorbed on graphene will 
modulate this charge density in the EDLs resulting in a change in the channel current as well as 
causing a shift in the Dirac point. If the adsorbed biomolecules are positively (or negatively) 
charged, the Dirac voltage will shift in the negative (or positive) direction. In other words, if more 
positive charges are attached to graphene, the applied voltage must be less positive in order to 






The charge transfer doping effect is caused by the direct charge transfer (Figure 3.10) from the 
adsorbed molecules to graphene channel especially when the adsorbed species are at low 
concentration or weekly charged. In this case, the adsorption density is quite small and the distance 
between the adsorbed molecules is larger than the Debye length of the channel material and the 
charge transfer is dominant between the adsorbed species and the channel material. The Dirac 
voltage shift caused by the charge transfer doping effect is in the opposite direction to that caused 
by the electrostatic gating effect. For example, if the adsorbed molecules are positively (or 
negatively) charged, the Dirac voltage will shift in the positive (or negative) direction [89]. 
 
Figure 3.10. Schematic illustration of doping effect in graphene field-effect transistor. 
 
Due to the several advantages EGFETs offer with respect to the biosensing applications, several 
groups have implemented this configuration for developing GFET based biosensors for highly 
sensitive detection of biomolecules. As an example, Wang et al. successfully used a label-free 
EGFET device for immunoglobin E (IgE) biomarker in human serum with a limit of detection in 
47 pM [91]. Hao et al. developed another EGFET biosensor for real-time monitoring of insulin 
with a limit of detection of 35 pM [79]. They also demonstrated that these GFET biosensors can 
find applications in clinical diagnostics for label-free monitoring of insulin and timely prediction 






3.2.2.3. Debye length  
One of the factors that limit the capabilities of GFET biosensors is the Debye length, which is the 
maximum distance away from the graphene surface beyond which the GFET device is able to 






where 𝑛 is the bulk concertation of ions in the solution, 𝑍 is the charge of the ion and 𝑒 is the 
charge of an electron. The Debye length can be approximated as: 
 





where c is the molar concentration of the buffer salt solution. For aptamer-based GFET sensors, 
the concentration of buffer solution should be such that the Debye length is essentially greater than 
the aptamer length.  
 
Another factor that limits the performance of a GFET biosensing device is the Faradic currents 
which are created by the reduction or oxidation of the molecules at the liquid-electrode interface. 
This causes an unwanted leakage current through the gate electrode. In general, Faradic currents 
should be less than 1 nA. One of the ways to reduce Faradic currents is by passivation of the 
electrodes with a layer of oxide to reduce the interaction between the electrode surface and the 
solution [93].  
 
3.3. Conclusion 
In this chapter, I discuss the theory of carbon-based nanoelectronics. Specially, two popular carbon 
nanomaterials, namely CNT and graphene are discussed—their electronic and electrochemical 
properties, manufacturing, as well as significance in biosensing. Moreover, I present a brief 










Aptamers hold great interest to the scientific community due to their versatile advantages with 
regards to biosensing. Their many advantages, including high affinity and binding efficiency to 
the target analyte, chemical and thermal stability, resistance to harsh environmental conditions, 
long shelf-life, mass producibility at low-cost, and reusability make aptamers attractive 
alternatives to their natural counterparts, such as antibodies and enzymes [54], [94]. Selected in 
vitro by a well-established technique known as the Systematic Evolution of Ligands by 
EXponential enrichment (SELEX), aptamers can be used for the selective detection of a broad 
range of analytes including proteins, peptides, amino acids, drugs, metal ions, and even whole cells 
[95]. The detection of lysozyme has received much attention among researchers because of its 
various significances in medicine, as well as in the food industry. Having a molecular weight of 
14.4 kDa with a primary sequence containing 129 amino acids and an isoelectric point of 11.0, 
lysozyme is a ubiquitous enzyme widely available in diverse organisms such as bacteria, 
bacteriophages, fungi, plants, and mammals [96], [97]. Lysozyme also plays an important role as a 
biomarker for diagnosing diseases such as breast cancer [98], Alzheimer’s disease [99], rheumatoid 
arthritis [100], malaria [101], AIDS [102], tuberculosis and leprosy [103], sarcoidosis [104], and 
Crohn’s disease [105]. Typically, the concentration of lysozyme in a healthy person’s saliva is 
13.8 µg/mL [59], whereas the concentration is 0.463–2.958 µg/mL in a healthy person’s serum 
[94]. 
 
Existing aptamer-based biosensors use different detection schemes such as high-performance 
liquid chromatography (HPLC), quartz crystal microbalance (QCM), surface plasmon resonance 
(SPR), and fluorescence-based optical detection. However, these methods suffer from several 
drawbacks as they are often time-consuming, expensive, operated by highly trained technicians, 
and performed in a laboratory setting [54], [106]. However, as an alternative, electrochemical 
detection offers the potential for a rapid, low-cost, and sensitive detection of the target species. 





sensitive tool for investigating the features of surface-modified electrodes [106]. EIS can be used 
to monitor the changes in the electrical properties of the biosensor at different stages, including 
different fabrication steps as well as the detection of target recognition events [26]. The unique 
advantages of EIS include the ease of signal quantification, the ability to separate the surface 
binding events from the solution impedance, non-invasive measurement, real-time monitoring, and 
label-free detection, making it an effective tool for electrochemical interrogation [26]. 
 
An important step towards the fabrication of the aptamer-based electrochemical biosensor is the 
immobilization of the aptamer probes onto the working electrode so that the target recognition by 
the aptamer can be transduced into a measurable electrical signal. Rohrbach et al. developed a 
lysozyme biosensor where the covalent coupling between the carboxylic groups of CNT and the 
amino groups linked to the aptamer was used to immobilize the aptamer [54]. An EDC/NHS 
coupling-based immobilization technique has been exploited by Kara et al. to develop an aptamer-
based biosensor for the detection of thrombin with a detection limit of 105 pM using EIS [53]. 
Others have used thiol-gold binding [59], [106], [107], biotin-avidin affinity-based binding [108], 
and surface adsorption [109] to immobilize aptamers on the respective electrodes. However, such 
approaches can be difficult to reproduce, often require complex chemistry, lack control over 
aptamer density, and may not be suitable for large-scale manufacturing and mass production. 
 
Herein, we explore the possibility of using the inkjet-printing technique for a reliable and 
reproducible aptamer immobilization method. We propose the use of a dispersed CNT-aptamer 
complex as a printable ink to be deposited on the electrode. The ink exploits the strong π–π stacking 
interaction between the nucleotide bases of the single stranded DNA and the sidewalls of the CNT 
[57]. Inkjet-printing is finding applications in areas such as flexible electronics, disposable sensors, 
and wearable devices [110]. Particularly, due to its on-demand printability of the devices, inkjet-
printed sensors can potentially be used as point-of-care (POC) diagnostic tools and disposable 
testing kits. In contrast to other existing aptamer immobilization techniques, the proposed 
approach of inkjet-printing offers many advantages, including mass producibility, uniform 
deposition of materials, fully automated process, and high throughput [110]–[112]. We also 
demonstrate in this work that the aptamer density can be controlled by utilizing the number of 





detection of lysozyme using EIS. The binding affinity of our aptamer probe to lysozyme was 
confirmed by the square wave voltammetric techniques using methylene blue (MB)-labeled 
aptamers (see Appendix B). 
 
Figure 4.1 presents the working principle of our proposed biosensor. Figure 4.1A shows the CNT-
aptamer complex deposited on the working electrode. Due to the negatively charged backbone as 
well as the insulating property of the aptamers, the charge (electron) transfer from the redox probe 
(e.g., ferro- and ferri-cyanide) to the electrode is hindered, i.e., the charge transfer resistance (Rct) 
is large as illustrated by the larger diameter of the Nyquist plot in Figure 4.1B. When the sensor is 
exposed to lysozyme as shown in Figure 4.1C, the aptamer unwraps itself from the CNT due to its 
preferential binding to the lysozyme. This conformational change in the aptamers opens up the 
path for electrons to easily flow from the redox probes to the working electrode, resulting in an 
enhancement in the rate of charge transfer and thus a reduction in Rct, as shown in Figure 4.1D 
with a smaller radius of the Nyquist curve. 
 
Figure 4.1. Working principle of the aptamer-based biosensor. Initially, the printed sensor blocks 
the charge transfer from the redox probe to the electrode due to the negative backbone of DNA 
bases (A); and the corresponding Nyquist curve (B). When exposed to the lysozyme, the anti-





opening up the current path for enhanced charge transfer (D); and the corresponding Nyquist curve 
(D). 
 
4.2. Materials and Methods 
4.2.1. Materials 
Multi-walled carbon nanotubes (>99.9% purity, 30–50 nm outer diameter, 10–20 µm length) 
modified with carboxyl functional groups (–COOH) were purchased from Cheap Tubes (VT, 
USA) and used without further modification. Single-stranded anti-lysozyme DNA 
oligonucleotides (sequence designed by Ellington and co-workers [113]) were synthesized by 
Sigma-Aldrich. The sequence of the oligonucleotides is: 5′-ATC AGG GCT AAA GAG TGC 
AGA GTT ACT TAG-3′. Methylene blue (MB)-labeled and thiolated DNAs with the same 
sequence (thiol group attached at the  5′ end MB attached at 3′ end) were purchased from LGC 
Biosearch Technologies (CA, USA). Lysozyme from chicken egg white, bovine serum albumin, 
and thrombin were also purchased as lyophilites from Sigma-Aldrich. The stock solutions were 
prepared by dissolving the lyophilites in fresh ultrapure triple-distilled water and stored at −20 °C 
until used. The diluted solutions of proteins were prepared in 50 mM phosphate buffer solution 
(PBS, pH 7.4, Sigma-Aldrich). 
 
4.2.2. Electrochemical Assay 
The Bio-Logic VSP-300 potentiostat was used for the electrochemical measurements. All 
experiments were performed using screen-printed carbon electrodes (SPCEs) purchased from 
DropSens (Spain). These disposable SPCEs consist of three electrodes: a carbon working electrode 
(WE), a carbon counter electrode (CE) and a silver pseudo reference electrode (RE). The WE is 
circular in geometry with a diameter of 4 mm. 
 
4.2.3. Ink Preparation 
First, 0.25 mg/mL of multi-walled carbon nanotubes (MWCNTs) were mixed with 5 µM lysozyme 
binding aptamer in 30% N-methyl pyrrolidone (NMP) solution. Next, the mixture was sonicated 
using an ultrasonic bath sonicator for 2 h and then centrifuged at 6000 rpm for 30 min in order to 
remove any MWCNT aggregates. Afterwards, the supernatant was collected and loaded into the 






The Fujifilm Dimatix Materials Printer (DMP-2831) was used for the inkjet-printing. It uses a 16-
jet Dimatix Materials Cartridge with 10 pL drop volumes. The minimum patterning resolution of 
this printer was reported to be 20 µm according to the product specification sheet. Each device 
was printed with 5 layers of the CNT-aptamer ink. The ink was printed at a voltage of 40 V, a 
nozzle temperature of 35 °C and a 5 kHz jetting frequency. The amount of ink printed per layer is 
estimated to be approximately 315 nL (see Appendix A for detailed calculation). 
 
4.2.5. Removal of the Unbound Aptamers 
After the printing process, the SPCE devices were dried on a hotplate at 35 °C and gently washed 
with deionized (DI) water to remove any unbound DNAs. The effect of washing is presented in 
Figure 4.2. 
 
Figure 4.2. The effect of washing on the printed sensor. After the first wash, the Rct value obtained 
from the Nyquist curve drops by approximately 31%. Subsequent washes do not significantly 
change the radius of the Nyquist curves, suggesting that the remaining aptamers are securely 
attached to the CNTs.  
 
It can be seen that the radius of the Nyquist curve corresponding to the first wash drops 
significantly and remains stable for the subsequent washes. This indicates that the majority of the 
unbound or loosely bound aptamers have been removed after the first rinsing procedure during 





4.2.6. EIS Measurements 
The electrochemical impedance spectroscopy (EIS) measurements were performed with 1 mM 
K4[Fe(CN)6]/K3[Fe(CN)6] (1:1) mixture (pH: 7.25) as a redox probe prepared in 10 mM PBS. The 
impedance was measured in a frequency range from 100 kHz to 100 mHz with a DC potential of 
0.115 V versus Ag pseudo reference with a sinusoidal AC voltage of 5 mV RMS. The sampling 
rate was 10 points per decade. The charge transfer resistance (Rct) of the equivalent circuit was 
obtained by fitting the measured Nyquist curve using a modified Randles circuit. 
 
First, the EIS measurement was taken on a CNT-aptamer ink-printed SPCE by placing a 50 µL 
droplet of the ferro-/ferri-cyanide solution on the surface of the electrode for obtaining the baseline 
measurement (this will be called pre-lysozyme measurement). Next, the same device was exposed 
to a 50 µL droplet of lysozyme of varying concentrations (0, 0.25, 0.50, 1, 2, 5, 10, and 20 µg/mL) 
and incubated for 15 min. The electrode was then rinsed with 50mM PBS buffer followed by 
rinsing in DI water to remove any unbound lysozyme protein. Afterwards, a second EIS 
measurement was performed to obtain the response of lysozyme binding with the aptamers (this 
will be called post-lysozyme measurement). 
 
After making two rounds of EIS measurements on the same device, one for the pre-lysozyme 
condition and one for the post-lysozyme condition, the Rct values were obtained by curve-fitting 
the Nyquist plot to the modified Randles circuit model. The relative change of the transduction 




× 100%                                                 (1) 
where Rct,pre and Rct,post denote the charge transfer resistances of the pre-lysozyme and post-
lysozyme measurements, respectively. 
 
4.2.7. Chronocoulometric Experiments  
To calculate the packing density of aptamers on the WE, chronocoulometry (CC) was performed 
by applying a pulsed voltage with a pulse width of 200 mV versus Ag pseudo reference and a pulse 
period of 10 s. First, the measurement was done with the sensor in 10 mM Tris-HCl buffer. Next, 





for 1 h. Then, the sensor was washed in DI water to remove any excess RuHex that was not bound 
to the DNA aptamer. Finally, the CC was performed for the RuHex incubated sensor. Following 
the experiment, the aptamer packing density was calculated from the CC intercepts at t = 0. See 
Appendix C for the experimental details. 
 
4.3. Results and Discussion 
4.3.1. Patternability of the CNT-Aptamer Ink 
The patternability of the aptamers has been characterized optically by fluorescence imaging. For 
the ink preparation, the aptamers were labeled with a fluorescence (6-FAM) modified at the 5′ end. 
Different numbers of layers (one to eight) were printed on a microporous PET transparency film 
as a single droplet array, as shown in Figure 4.3A. The droplet array was washed with DI water 
before imaging to remove loosely adsorbed aptamers that remained from the ink. The intensity 
profile of the array is presented in Figure 4.3B against the number of printed payers. It can be seen 
that, for the number of print layers from one to six, the fluorescence intensity is proportional to the 
number of layers. However, for seven and eight layers of printing, the intensity decreases slightly. 
This decrease in intensity for higher number of layers can be attributed to the possible quenching 
of the fluorophore due to the overcrowding of the aptamers that can lead to the cross-hybridization 
among neighboring aptamers, a potential result of the self-complimentary nature of the individual 
aptamer sequences [114]. Furthermore, the coffee ring effect [115] becomes more pronounced for 
higher number of layers, as can be seen in Figure 4.3A. In summary, we have demonstrated the 
ability to control the density of the immobilized aptamer by choosing the proper number of printed 
layers. Furthermore, a minimum patterning resolution of 40 µm was obtained with the CNT-
aptamer ink. Figure 4.3C shows the scanning electron microscope (SEM) image of the CNT-







Figure 4.3. (A) Fluorescence image of the printed CNT-aptamer ink in a single-droplet array with 
different numbers of layers (as indicated by the numbers in the image); and (B) the intensity profile 
of the printed circles versus the number of layers. Each droplet has a diameter of 40 µm; (C) shows 
an SEM image of the CNT-aptamer ink used for lysozyme recognition. 
 
4.3.2. Characterization of the Sensor 
Figure 4.4 shows the Nyquist curves of the SPCE with different modifications on the working 
electrode: (a) bare device, (b) with CNT ink printed, and (c) with CNT-aptamer ink printed. When 
the electrode is printed with CNT only, the charge transfer resistance (Rct) decreases due to the 
highly conducting nature of MWCNT. However, when the electrode is printed with the CNT-
aptamer ink, the Rct increases significantly due to the negative charges of the single-stranded DNA 






Figure 4.4. The Nyquist curves obtained with electrochemical impedance spectroscopy (EIS) 
measurements at different modification stages of the electrode: (a) bare screen-printed carbon 
electrode (SPCE); (b) printed with CNT ink; and (c) printed with CNT-aptamer ink.  Aptamer 
wrapping to CNTs significantly increases the charge transfer resistance (Rct) due to the negative 
backbone of the DNA aptamers.  
 
Figure 4.5 compares the responses of the printed sensor before and after exposure to the target 
protein biomarker. As can be seen from the figure, when the sensor is exposed to lysozyme, Rct 
decreases considerably. This can be attributed to the conformational changes of the anti-lysozyme 
aptamers upon specific binding to the target, resulting in an unwrapping of the DNAs from the 
CNTs. The unwrapped aptamers are then removed from the device via rinsing the electrode, 






Figure 4.5. Effect of lysozyme exposure on the printed sensor. Nyquist curves for (a) pre- and (b) 
post-lysozyme conditions. It can be observed that lysozyme (1 µg/mL) exposure reduces the 
charge transfer resistance (Rct) because of the unwrapping of the anti-lysozyme aptamers from the 
CNTs to capture the lysozyme protein.  
 
Lysozyme binding of the aptamers was further confirmed by comparing the responses of the 
printed devices with those of bare SPCEs. As summarized in Figure 4.6, the change in Rct is much 
larger for the printed sensor than for the bare electrode. The Rct changes in the bare electrodes are 
likely due to the non-specific adsorption of the target biomarker on the electrode surface. 
 
Figure 4.6. Change of charge transfer resistance (Rct) due to lysozyme exposure to bare SPCE 
(black bars) and printed SPCE (red bars) for different lysozyme concentrations. 
 
4.3.3. Packing Density of the Aptamer Probes 
The theoretical number of aptamer probes printed on the working electrode can be calculated as 
follows: 
𝑛 = 𝑀 ×  𝑉 × (1 − 𝜒) ×  6.023 ×  1023  (2) 
where n is the number of aptamer molecules, M is the molarity (=5 µM) of the aptamers in the ink, 
V is the volume (=1.575 µL) of ink printed (see Appendix A), and χ accounts for the fraction of 
aptamers not attached to the CNT during the sonication-assisted dispersion of the CNT-aptamer 














2⁄ + Qdl + QSE       (3) 
  
where n is the number of electrons per molecule for reduction, F is the Faraday constant (96485.33 
C/mol), A is the electrode area (cm2), Do is the diffusion constant (cm
2/s), Co is the bulk 
concentration (mol/cm3), t is the time (s), Qdl is the double layer capacitive charge (C/mol) and 
QSE is the surface excess charge (C/mol) from the reduction of the adsorbed redox marker. QSE is 
related to the density of the redox probe, ᴦ0 (mol/cm





The value for QSE can be calculated from chronocoulometry experiments. The chronocoulometric 
intercept at t = 0 is the sum of the double layer capacitive charge and the surface excess charge. 
The surface excess charge (QSE) is determined from the difference in chronocoulometric intercepts 
(at t = 0) in the presence and absence of the redox probes for the identical potential steps. The 




 𝑁𝐴  (5) 
where z is the charge of each redox molecule, m is the number of nucleotides in the aptamer base 
sequence, and NA is Avogadro’s number. Chronocoulometry was performed for different number 
of printed layers (see Appendix A). The experimentally calculated packing density for different 
number of layers is plotted in Figure 4.7. The graph shows that the packing density increases with 
increasing number of printed layers, and then saturates for further number of layers. This saturation 
effect can presumably be attributed to the steric and electrostatic repulsion among the negatively 
charged aptamers [117].  
 
Now if equation (2) is used to linearly fit the experimental data points of Figure 4.7, the value of 
χ can be estimated as χ = 98.7%. Therefore, the number of aptamer molecules printed per layer on 
the WE (area: 0.12 cm2) of the electrode can be estimated as 1.23 × 1010 molecules per layer. 





layer. Furthermore, using this value of χ, the final concentration of the aptamers present in the 
printed ink can be estimated as 65 nM. 
 
Figure 4.7. Packing density of aptamer probes as a function of number of printed layers. 
 
The influence of the number of printed layers on the sensing performance was also characterized. 
As presented in Figure A4 in Appendix A, it was observed that the sensor response experiences a 
nearly linear increase (region 1) with increasing number of printed layers until it reaches a plateau 
and then decreases afterwards (region 2). This is because at lower number of printed layers (region 
1), the sensitivity is proportional to the concentration of aptamer receptors, i.e., more aptamers 
lead to increasing binding. However, for increased number of layers (region 2), the aptamers that 
are buried deep in the printed ink are not able to bind with the protein and hence remain as electrical 
insulators, resulting in poor sensitivity. The plot in Appendix A illustrates the influence of the 
number of printed layers on the sensor’s sensitivity. Also, the sensor’s response time correlates 
with the thickness of the printed layers, in other words, the number of prints on the electrode. In 
our experiments, all devices were printed five times for lysozyme detection. 
 
4.3.4. Performance of the Aptamer Sensor 
The performance of the aptamer sensor has also been characterized by measuring the relative 
change in sensor response for different concentrations of lysozyme analyte. The results are 






Figure 4.8. (a)–(h) Pre- and post-lysozyme Nyquist curves for different concentrations of lysozyme 
(0, 0.25, 0.5, 1, 2, 5, 10, 20 µg/mL, respectively) in 50 mM PBS as well as (i) post-lysozyme 





4.3.5. Modelling of the Nyquist Curves 
The pre- and post-lysozyme Nyquist curves can be modelled by the modified Randles circuit 
shown in Figure 4.9, where RS is the solution resistance, Rct is the electron transfer resistance, CPE 
(constant phase element) represents the double layer capacitance at the solution–electrode interface 
for a rough surface [118], and W1 is the Warburg impedance. 
 
Figure 4.9. Modified Randles circuit representing the equivalent circuit model to fit the Nyquist 
curves of the EIS measurements. 
 
The CPE accounts for the roughness of the electrode surface and, mathematically, its impedance 





where j is the imaginary unit, and α1 and Q1 are the characteristic parameters of the constant phase 
element. The introduction of the CPE instead of a simple capacitance is particularly important for 
the modelling of primary protein layers on the electrode surface, and the parameter α1 was found 
to vary between 0.925–0.961 for our sensor devices. For α1 = 1, the CPE turns into a simple 
capacitance. W1 is the circuit element corresponding to Warburg impedance resulting from the 
semi-infinite diffusion of ions from the bulk electrolyte to the electrode interface and is 





where δ1 is the characteristic value of the Warburg element. Table 4.1 summarizes the modified 





Table 4.1. Randles circuit parameters for the post-lysozyme Nyquist curves in Figure 4.8I (Data 
extracted using Zfit program of Bio-Logic EC-Lab software).  
Lys Concentration 
(µg/mL) 
Rct (ohms) CPE (µF∙s



















































Figure 4.10 shows the theoretically fitted post-lysozyme Nyquist curves based on the modified 
Randles circuit (red solid lines). The dotted lines represent the experimental data. The graph shows 
good agreement between the experimentally obtained Nyquist curves and those obtained from the 
theoretical model. 
 
Figure 4.10. Post-lysozyme exposure Nyquist curves for different concentrations of lysozyme: (a) 





and (h) 20 µg/mL. The dotted lines are the experimental data and the solid lines in red are the 
theoretically fitted curves based on the modified Randles circuit.  
 
The calibration curve for our aptamer-based sensor is presented in Figure 4.11. It shows that for 
low concentrations of lysozyme, the sensor exhibits high sensitivity and at higher concentrations  
(5 µg/mL and above) the sensor’s response reaches a saturation. Based on this calibration curve, 
the detection limit was calculated to be 90 ng/mL. (See Appendix A for the formula used for 
calculation). 
 
Figure 4.11. Relative change in charge transfer resistance (Rct) after lysozyme exposure with 
varying concentrations (0, 0.25, 0.50, 1, 2, 5, 10, and 20 µg/mL). Error bar shows 1 standard 
deviation with n = 3. The inset graph shows the magnified plot for low concentration range from 
0 to 5 µg/mL.  
 
4.3.6. Selectivity of the Aptamer Sensor 
The selectivity of our aptamer-based lysozyme sensor was investigated against two other proteins: 
thrombin (THR) and bovine serum albumin (BSA). It is clear from Figure 4.12 that our aptamer-
based biosensor is highly selective toward lysozyme. The non-zero responses for THR and BSA 
can be attributed to the non-specific adsorption of the proteins on the sensor. Although the 
aptamers were designed to selectively bind with lysozyme, THR and BSA do have some level of 
affinity with the aptamers, resulting in a false recognition of the analyte. However, the non-specific 





markedly smaller compared to the specific target recognition by lysozyme. Better optimization of 
the aptamer sequence is expected to further enhance the target selectivity. For instance, a 42-mer 
aptamer sequence (ATC TAC GAA TTC ATC AGG GCT AAA GAG TGC AGA GTT ACT 
TAG) is reported to have improved binding efficiency [121], which could further reduce the 
response from THR and BSA. 
 
Figure 4.12. Selectivity of the aptamer biosensor to lysozyme against other proteins such as 
thrombin and bovine serum albumin for different concentrations. 
 
4.3.7. Long-Term Stability (Shelf-Life) of the Aptamer-Printed Biosensor 
The shelf-life or the long-term storage stability of the developed biosensor was investigated by 
storing the fabricated devices for a period of up to 35 days at room temperature. After the storage 
period, the sensor was tested by measuring the Nyquist curves for the pre-exposure and post-
exposure measurements with the lysozyme concentration of 1 μg/mL. As can be seen from Figure 
4.13, the sensor response is reasonably consistent (with a tolerance of ±1.73%) for the first 21 
days, then experiences a drop in the resistance change afterwards. Hence, it can be concluded that 
our proposed sensor is stable for 21 days at room temperature. However, it is expected that the 
shelf-life would be further extended if the devices were stored in a cooler temperature, such as at 
4 °C. Moreover, because we are utilizing an inkjet-printed sensor, one advantage is that the sensor 






Figure 4.13. Shelf-life of the fabricated aptamer-based biosensor. The sensor response is plotted 
against the number of stored days at room temperature. 
 
4.3.8. Comparison to Other Aptamer-Based Lysozyme Sensors 
In order to compare the sensing performance presented in this work with other recently reported 
lysozyme sensors, Table 4.2 summarizes the detection limit (LOD), linear range, immobilization 
method, and detection mechanism of several recently published works. The table demonstrates 
that the sensor presented in this work shows comparable performances with other reported sensors. 
However, the main advantage and novelty of the proposed device is the convenience and the ease 
of immobilizing and patterning the aptamers on the electrode using the precision inkjet-printer for 
low-cost and disposable sensor development. 
 
Table 4.2. Comparison of the sensing performances of recently published lysozyme sensors. 
 












1.4 fg/mL–14 ng/mL 
14 ng/mL–1.12 µg/mL 
1.4 fg/mL–6.96 pg/mL 
0–10 µg/mL 



































An inkjet-printed aptamer-based biosensor has been developed for the label-free selective 
detection of lysozyme biomarker. Electrochemical impedance spectroscopy was used as the 
interrogation method. The selectivity of the sensor was tested against BSA and thrombin and was 
shown to be selective towards lysozyme. The limit of detection was calculated to be 90 ng/mL. 
The sensor also demonstrates a reasonable shelf-life of around 21 days at room temperature. 
Although we have demonstrated the feasibility of inkjet printing-based sensor development for 
lysozyme detection, our next step in the future work is to further characterize this sensing platform 
with real physiological samples such as saliva or blood serum to ensure that the results can be 
replicated. The proposed inkjet-printed biosensor has potential applications in point-of-care 
diagnostics by enabling low-cost, label-free, fast detection, and on-demand printability so that 














 GRAPHENE FET AS A SENSITIVE 
DETECTION PLATFORM FOR BIOSENSOR 
 
5.1. Introduction 
Lysozyme is a ubiquitous enzyme that is widely available in diverse organisms, such as bacteria, 
bacteriophages, fungi, plants, and mammals. Being an antimicrobial protein, lysozyme is often 
called the “body’s own antibiotic” [59], [96]. The protein is also extensively exploited in food 
industries for several purposes such as preserving meat and dairy products, as well as fruits and 
vegetables. The molecular weight of lysozyme is 14,400 Da with a primary sequence containing 
129 amino acids and it has an isoelectric point of 11.0 that causes lysozyme to behave as positively 
charged at neutral pH [96]. In addition to its extensive use in food industry, lysozyme also plays a 
vital role as a biomarker for diagnosing various diseases such as breast cancer [98], Alzheimer’s 
[99] and rheumatoid arthritis [100].  
 
In the past, several biosensing techniques have been deployed for effective detection of lysozyme 
molecules. Some of these methods include chromatographic or antibody-based techniques [124], 
sensitive colorimetric detection [125], surface plasmon resonance (SPR)-based approach [126] and 
electrochemical impedance spectroscopy (EIS) measurement [127], [128], to name a few. Among 
these sensing techniques, field-effect transistor (FET)-based sensing offers several advantages 
including miniaturization, low cost, and large-scale integration with other sensors as well as rapid 
detection and high sensitivity [129]–[131].  
 
A typical FET biosensor is comprised of a semiconducting channel contacted between the source 
and the drain electrodes. Upon adsorption of the biomolecules on the semiconductor surface, a 
change in the electric field occurs which affects the gate potential of the device resulting in a 
change in the charge carrier density within the channel of the FET. Such change in the drain current 
can be conveniently measured and be utilized as an interrogation strategy to probe the adsorbed 
biomolecules. This type of sensing mechanism has been demonstrated in the past for detecting 
target analytes in gases, water as well as in human serum [28]–[31], [89]. Two-dimensional (2D) 





material for FET-based biosensors due to their planner structure, excellent electrical properties, 
and high surface area-to-volume ratio. Among several 2D materials graphene has been widely used 
as a promising FET channel material for various analyte detection due to its superior physical and 
chemical properties: namely high intrinsic carrier mobility, good biocompatibility, high stability, 
and flexibility, which are all desirable traits to have for biosensing applications. For example, 
chemical vapor deposition (CVD)-grown graphene-based FET (GFET) biosensors have been used 
to detect triphosphate [132] and binding kinetics of DNA hybridization [88]. Similarly, Huang et 
al. and Chen et al. have successfully demonstrated the detection of bacteria [133] and Ebola antigen 
[134] using graphene-based FETs. Nonetheless, the detection of protein molecules using FET 
biosensors is largely limited by the charge screening effects of the non-specifically adsorbed 
surface molecules from the buffer solution. To overcome this issue, the graphene channel surface 
is typically modified with target receptors which enable specific binding reaction with the charged 
target protein molecules in the solution. For example, Ohno et al. reported that in an aptamer-
modified GFET, a non-specific binding of the non-target protein molecules was suppressed [135]. 
However, this technique is still limited for specific detection of small and weakly-charged analytes 
which do not directly induce detectable changes in surface charge after molecular binding. 
Moreover, the detection of lysozyme protein via a GFET-based biosensing platform has not yet 
been demonstrated so far. Therefore, in this work, we describe the selective detection of lysozyme 
molecules utilizing large area CVD-grown GFET devices prepared by a facile one step transfer 
process. 
 
The fundamental operating principle of the GFET biosensor is illustrated in Figure 5.1. Figure 
5.1(a) depicts the schematic of the liquid-gated GFET device. CVD-grown large area graphene is 
contacted with source and drain electrodes. Single-stranded probe DNAs (pDNA), which act as 
target-binding aptamers, are securely anchored onto the graphene surface, via the bifunctional 
linker 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE). A sample ionic buffer solution 
is dropped on the surface of the GFET channel. Upon applying a gate voltage (VGS), between the 
gate electrode in the solution and the source electrode of the GFET channel, the electrical double 
layer (EDL) is formed at the interface between the graphene channel and the electrolyte [136]. 
This formation of EDL induces image charges in the channel and provides high gate capacitance. 





demonstrates the IDS-VGS characteristics of the GFET. A typical ambipolar electric field-effect 
characteristics is expected for the top-gate operation with -1 V ≤ VGS ≤ 1 V. The minimum IDS 
occur at the charge neutrality point VCNP also known as the Dirac voltage (VDirac), which signifies 
the demarcation between the p-type and the n-type conduction of the graphene channel. Therefore, 
the VCNP represents the doping level in the graphene channel. Since the surface-analyte or analyte-
analyte bindings occur in the proximity of the graphene surface, the analyte-analyte bindings can 
significantly change the doping level in the graphene channel. This change in the doping level 
results in a detectable shift in VCNP as shown in Figure 5.1b.  
 
Figure 5.1. (a) Schematic representation of top liquid-gated graphene FET device with anchored 
pDNAs on the graphene channel surface. (b) IDS-VGS characteristics of graphene FET device 
before and after target molecule binding resulting in a detectable change in VCNP.  
 
5.2. Materials and Methods 
5.2.1. Materials 
The amino linker modified anti-lysozyme DNA oligonucleotide (sequence designed by Ellington 
and co-workers [113] was synthesized by Sigma-Aldrich. The sequence of the oligonucleotide is: 
5′-amino-C6-ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-𝟑′. Lysozyme protein from 
chicken egg white was also purchased from Sigma-Aldrich. Protein stock solutions were prepared 
by dissolving the lyophilites in fresh ultrapure triple-distilled deionized water and stored at -20˚C. 





7.4). PBS was obtained from Sigma-Aldrich. Tween 20 and 1-pyrenebutyric acid N-
hydroxysuccinimide ester (PBASE) were purchased from RPI Research Products International 
(IL, USA) and Santa Cruz Biotechnology (TX, USA), respectively.  
 
5.2.2. Fabrication of GFET 
Figure 5.2 shows the transfer process of large area CVD grown graphene from SiO2/Si substrate 
onto the prefabricated 4 independently addressable gold electrodes. The CVD grown graphene 
sample was purchased from Graphene Supermarket (NY, USA). The transfer process begins with 
spin coating onto the graphene a support layer of poly (methyl methacrylate) (PMMA) at 3000 
RPM followed by immersion into 6 M KOH solution for 30 min at 800C. This results in etching 
of the underlying SiO2 layer and separation of the top PMMA/graphene bilayer from the substrate. 
The PMMA-protected graphene layer was then collected on top of the pre-fabricated gold 
electrodes and dried at room temperature. The electrodes were then immersed into acetone for 12 
hours to dissolve the top PMMA layer followed by consecutive washing with ethanol and DI water. 
Finally, the devices were annealed at 250°C for 2 hr in an Argon-filled chamber to reduce any 
PMMA residues [137]. 
  
 






5.2.3. Electrical FET measurements 
All electrical measurements were carried out using the Keysight precision source/measure unit 
(B2902A) combined with a probe system (Micromanipulator: 450PM-B). For FET measurements, 
solution-gate experiments were performed. A constant bias voltage VDS = 100 mV was applied 
across the drain and the source terminals by connecting the two manipulator needles to the source 
and the drain electrodes. The gate voltage VGS (-1 V≤ VGS ≤ +1 V) is applied by immersing the 
third manipulator needle into the sample droplet of 0.01× PBS buffer solution placed on top of the 
GFET devices. 
 
5.2.4. Functionalization of GFET  
Immobilization of the pDNAs onto the graphene surface was performed by incubating the 
graphene chip in the bifunctional linker 1-pyrenebutyric acid N-hydroxysuccinimide ester 
(PBASE) at 10 mM in dimethyl formamide (DMF) at room temperature for 20 hr. The aromatic 
pyrenyl group of PBASE binds to the basal plane of graphene through noncovalent π − π 
interactions [138]. This was then followed by rinsing the chip sequentially in DMF, ethanol and 
DI water for 3 min each. In the final step, the chip was incubated with the aminated (5’) probe-
DNA at 5 µM in 0.01× PBS at room temperature for 12 hr to covalently link the pDNA to the 
PBASE via an N-hydroxysuccinimide (NHS) crosslinking reaction [139]. To remove the 
unanchored pDNAs, the chip was successively rinsed with 0.1× PBS and DI water. Following the 
probe attachment, the chip was treated with 0.1% Tween 20 followed by sequential rinsing in 
0.05% Tween 20 and DI water. Finally, the chip was incubated in different concentrations of target 
proteins in 0.1× PBS for 30 min. This allows lysozyme binding due to the sequence-specific high 
affinity of the aptamers to lysozyme [23], [54]. Afterward, the chip was rinsed with 0.01× PBS 
buffer followed by DI water and dried with a compressed air gun before performing the electrical 
measurements. 
 
5.3. Results and Discussion 
5.3.1. The effects of functionalization and DNA immobilization on the FET measurements  
For the selective protein detection, the graphene layer is successively functionalized by PBASE 
and the single-stranded probe DNAs (pDNAs) specifically designed for lysozyme binding [113]. 





conducting channel formed between the source and the drain electrodes on the SiO2/Si substrate 
as schematically depicted in Figure 5.1(a). PBS solution (0.01×) was used as the top gating 
dielectric. The pyrene group terminated PBASE is coupled to the graphene surface via the π-π 
stacking forces [88]. The 5′- amino-modified pDNAs were attached to the amine-reactive 
succinimide group of PBASE by the conjugation reaction between the amine groups. The IDS−VGS 
characteristics of the GFET devices were measured sequentially after each functionalization step 
and exposure to the target lysozyme molecules. The binding of the lysozyme molecules to the 
pDNAs induces changes in the charge carrier density in the graphene channel. This causes a 
detectable change in the Dirac voltage (VDirac) or the charge neutrality point (VCNP) in the IDS−VGS 
characteristics of the GFET. 
 
Figure 5.3 shows the IDS-VGS characteristics of a GFET device at each stage during the surface 
modification process. The IDS-VGS characteristics exhibit ambipolar behavior as the gate voltage in 
the top-gate dielectric (0.01×PBS) changes from -1 V to +1 V similar to previously reported 
measurements [88]. The VCNP for the unmodified GFET was found to be 203.96 mV. Since the 
graphene channel is sensitive to any surface adsorptions or modifications, the VCNP was shifted left 
at 40.8 mV relative to the unmodified graphene channel after the PBASE linker modification. 
Previously, Wu et al. reported that PBASE modification of graphene causes n-doping in the 
graphene channel after long incubation in the DMF solvent [140]. Therefore, left shift of VCNP in 
our experimental results suggests n-doping of the graphene channel. Figure 5.3(c) shows the IDS-
VGS characteristics of the GFET after the pDNA attachment. Here, we note that the VCNP further 
shifted left with respect to that after PBASE modification (Figure 5.3(b)) indicating further n-
doping of the graphene channel. It has been widely observed and speculated that the presence of 
electron rich nucleotide bases in the DNA molecules can cause n-doping effects in carbon 
nanotubes and graphene [141], [142]. We have further treated the GFET devices with 0.1% Tween 
20 solution in deionized water in order to minimize non-specific adsorption. Due to its high affinity 
with graphene, Tween 20 has been extensively used in the past to deter non-specific binding of 
proteins as well as to remove non-specifically adsorbed probe DNAs on the graphene [139]. 
However, the presence of the surfactant adsorbates can effectively dope the graphene channel. 
Among various surfactants, Tween 20 has been reported to cause n-doping effect on the graphene 





consistent with an increased n-doping effect as indicated in Figure 5.3(d). We further notice a 
small change in the minimum current at VCNP that after each step of functionalization. Due to 
atomically thin nature, the minimum conductance at the charge neutrality point VCNP in GFET 
devices are extremely sensitive to several extrinsic factors such as charge impurities, doping 
density, external ions etc. [144], [145]. Previously it was also reported that the minimum 
conductance can also be affected by the presence of   PBS buffer ions [141]. Thus, we believe that 
the small changes in the minimum current at VCNP in our GFET devices are caused due to doping 
effect after surface modification and/or due to the ionic adsorption or desorption effects of the PBS 
buffer ions.  
 
Figure 5.3. IDS-VGS characteristics of the graphene FET device (a) before any surface modification 
(unmodified graphene); (b) after PBASE functionalization; (c) after attaching single-strand 
pDNAs to the PBASE linker; and (d) after treating the graphene surface with 0.1% Tween 20.  
 
5.3.2. Concentration Dependent Shift in the Charge Neutrality Point 
Figure 5.4(a) shows the IDS-VGS characteristics of the GFET device when exposed to varying 
concentrations of lysozyme samples. The graphene devices were first incubated in 0.01× PBS 
buffer solution containing the lysozyme protein for 30 mins followed by a gentle wash in PBS and 





10 nM lysozyme solution, the VCNP shifted to -449 mV. This results in a positive shift of VCNP of 
20.5 mV with respect to the VCNP = -469.5 mV at 0 nM lysozyme. VCNP shifts further right with 
the increasing lysozyme concentration. The lysozyme binding with the pDNA aptamer (5′-amino-
C6-ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-3′) was previously confirmed by 
[96]. It was also found that at neutral pH, lysozyme is positively charged with net +8 charges [96], 
[146]. Therefore, the presence of lysozyme molecules in the proximity of the graphene nanosheet 
can induce a p-doping effect in the FET channel. Thus, the positive shift of the VCNP can be 
attributed to the reduction of n-doping effects during the previous functionalization steps. Further, 
our results suggest a strong correlation between the lysozyme concentration and the degree of the 
VCNP shift in the right direction: the higher the lysozyme concentration, the further the VCNP shifts 
to the right. Figure 5.4(b) shows the relative shift of VCNP (ΔVCNP) (with respect to the position of 
VCNP after exposure to 0 nM lysozyme concentration) after exposing the GFET devices to a series 
of lysozyme concentrations in the range from 10 nM to 10 µM. From the FET responses, we have 
found that ΔVCNP increases sharply for the lower concentrations of lysozyme and then gradually 
reaches saturation at approximately 1µM and beyond.  
 
Figure 5.4. (a) IDS-VGS characteristics of the graphene FET-based biosensor device when it is 
exposed to varying concentrations of lysozyme protein; (b) the calibration curve for the GFET-
based biosensor showing ΔVCNP as a function of different concentrations of lysozyme. The 





To further verify the specific lysozyme binding with the pDNA aptamers and subsequently to 
characterize the selectivity of the GFET biosensor devices, we also prepared GFET devices but 
without the presence of pDNAs. After successive functionalization with PBASE linker and 0.1% 
Tween 20, the devices were exposed to 1 µM lysozyme solution. The IDS-VGS curves obtained 
from the GFET without pDNAs are shown in Figure 5.5(a). Here we found that, after exposure to 
the lysozyme molecules, there is only a very small shift in VCNP (ΔVCNP =10 mV). This slight 
change in VCNP can be attributed to the small amounts of non-specific surface adsorptions of the 
lysozyme proteins on the surface of the graphene sheet. Similarly, we tested pDNA functionalized 
GFET devices against another non-specific target protein bovine serum albumin (BSA). As 
expected, due to the lower binding affinity of the pDNA aptamers with BSA, negligible changes 
in VCNP were observed.  Figure 5.5(b) compares the overall sensor responses of the three GFETs, 
two with the pDNA modification against lysozyme and BSA and one without the presence of 
pDNAs against the lysozyme (3 separate devices in each group). These results clearly indicate that 
our graphene-pDNA FET devices can selectively detect lysozyme molecules with significant 






Figure 5.5. (a) IDS-VGS characteristics of graphene-PBASE FET (without pDNA) device before 
and after exposure to 1µM lysozyme; (b) Comparative bar-chart showing the ΔVCNP of the 
graphene-PBASE FET devices with the pDNA functionalization after exposure to 1µM lysozyme 
and 1µM BSA and without pDNA functionalization (n = 3, error bar = 1 standard deviation, paired 
Student’s t-test, ***p < 0.001).); (c) the schematic diagram of the GFET with pDNAs (left) and 
without pDNAs (right). 
 
5.4. Conclusion 
We have presented aptamer-modified large area CVD-grown graphene FET biosensor for the 
detection of lysozyme protein biomarker. The FET biosensor is sequentially functionalized with 
PBASE crosslinker, an aptamer specifically designed for the molecular recognition of lysozyme 
protein and Tween 20 as a blocking agent for minimizing non-specific adsorptions on the graphene 
channel surface. We have demonstrated that the lysozyme molecules have specifically bound to 





in the shifting of the charge neutrality point. Consequently, this change in the charge neutrality 
point potential of the graphene-FET devices was utilized to quantify the bound lysozyme 
concentration. The graphene-FET biosensor devices were tested for the detection of the lysozyme 
biomarker with concentrations ranging from 10 nM to 1 µM in the PBS buffer, demonstrating its 
capability as a specific biomarker sensor. Furthermore, the dynamic drain-source current 
measurement with respect to varying lysozyme concentrations would be essential for the 
demonstration of real-time monitoring of lysozyme molecules. In terms of health diagnostics 
application, this technology can potentially be used for facile development of large-scale point-of-
























 GFET-MICROFLUIDICS AS AN 




Graphene, a 2D material of one atomic layer thickness, shows a plethora of interesting properties 
[147]–[154] such as high carrier mobility, large specific surface area, excellent electrical 
conductivity, planar structure, potential biocompatibility, high stability and flexibility. As a result, 
graphene materials have been used in many electronic applications including photodetectors [149], 
[150], capacitors [152] as well as biosensors [153]. Specifically, the utilization of graphene as a 
conduction channel in a field-effect transistor (FET) has been shown by us and others to have 
potential for sensitive biodetection [27], [154], [155][29]. To date, there exist many different 
detection principles in biosensors such as electrochemical impedance spectroscopy [23], [54], 
[106], high-performance liquid chromatography (HPLC), quartz crystal microbalance (QCM) 
[156], [157], surface plasmon resonance (SPR) [158] and fluorescence based optical detection 
[159], [160] to name a few. However, there are some limitations with these techniques such as 
tedious sample preparation as well as sophisticated and expensive instrumentation with consistent 
need for trained operators. By contrast, FET-based detection offers a variety of advantages such 
as high sensitivity, fast detection time, easy integration with the integrated circuit (IC) 
manufacturing process, miniaturization, low-cost, continuous real-time sensing and label-free 
detection [129]–[131].  
 
A Graphene FET (GFET) biosensor works either by the electrostatic gating effect or direct charge 
transfer to graphene, also known as the doping effect, or a combination of both [79], [89].  In the 
case of electrostatic gating, any adsorption of charged biomolecules on the channel surface causes 
a change in the electric field that modulates the current through the channel between the source 
and the drain. By contrast, the doping effect changes the channel conductance as a result of direct 
charge transfer between graphene and the biomolecule in contact with the graphene surface [141], 





appropriate sensing response. For example, if the doping effect is dominant, the current increases 
in a p-type semiconducting channel, whereas if the gating effect is dominant, the conduction 
current decreases [89]. This change in the drain current can be utilized as an interrogation strategy 
to probe the adsorbed biomolecules. Moreover, the ambipolar transfer (drain current vs. gate 
voltage) curve of the GFET devices provides an additional sensing mechanism by measuring the 
surface charge-induced shift in the Dirac voltage (∆VDirac) which is defined as the gate voltage at 
minimum drain current. Hence, the GFET as a biosensing platform has been applied for the 
detection of various target analytes including antigens, antibodies and charged molecules [27], 
[32], [79], [82], [83], [88], [163].  
 
Thrombin is an important protein biomarker for a number of diseases as it plays a central role in 
several cardiovascular diseases and the regulation of tumor growth. It is also responsible for 
thrombosis and platelet activation and therefore, is involved in many processes such as 
inflammation and tissue repair at the blood vessel wall [164]. Hence, the selective and sensitive 
detection of thrombin will be useful in surgical procedures and cardiovascular disease therapy. 
Moreover, thrombin is positively charged [165], [166] at neutral pH enabling it to be detected on 
a graphene-based sensing platform. Existing thrombin biosensors commonly use either antibodies 
or aptamers as the target capture probe to enhance selectivity. Recently, aptamers have become a 
popular choice of target receptors due to a number of advantages they offer compared to antibodies 
including shorter length and simpler structure, lower cost, higher stability in harsh environmental 
conditions, longer shelf-life and mass-producibility. Moreover, they can be selected in-vitro with 
high affinity for a wide range of analytes ranging from proteins, peptides, amino acids, drugs, 
metal ions and to even whole cells [9].   
 
Although GFET-based biosensors have been frequently reported [27], [167], [168], when it comes 
to analyte liquid control, a small volume of sample droplet is often placed over the graphene 
surface to form a liquid gate which is exposed to the open atmosphere. This type of sensing 
arrangement makes the sample loading and disposal difficult to control and also makes the device 
vulnerable to external disturbances such as evaporation. These factors could lead to inaccurate 
measurements and poor sensing performances. Furthermore, measurements taken during static 





[169]. Therefore, in efforts to address such challenges, the integration of the GFET device with a 
microfluidic system is implemented. 
 
The integration of microfluidics to biosensors has emerged as a promising approach in biomedical 
applications as microfluidics offer numerous advantages over traditional assays. Conceptually, 
microfluidics is the manipulation of fluids in submillimeter length scale with technologies first 
developed by the semiconductor industry and later expanded by the micro-electromechanical 
systems (MEMS) field. Commonly known as miniaturized Total Analysis System (µTAS) or Lab-
on-a-Chip (LoC) technologies, microfluidic technologies have been applied to biomedical research 
in order to (1) streamline complex assay protocols, (2) to reduce the sample volume and detection 
time substantially, (3) to reduce the cost of reagents while maximizing the information collected, 
(4) to enable automated measurement with high throughput, (5) to potentially enhance the 
sensitivity by increasing surface-to-volume ratio, and (6) to enable portability, disposability and 
real-time detection [170]–[172]. Moreover, integration to microfluidic channels improves the 
accuracy of measurements by preventing evaporation of buffer solution [173]. To exploit these 
advantages of the microfluidic technology, the integration of GFET biosensors and microfluidics 
has been proposed by several research groups. For example, Islam et al. have developed a 
microfluidic GFET biosensor for femtomolar detection of chlorpyrifos [163]. Yang et al. have 
built a microfluidic aptasensor that combines aptamer-based selective analyte enrichment, isocratic 
elution with GFET-based nanosensing for sensitive and label-free detection of small biomolecules 
[174]. Saltzgaber et al. have demonstrated a large-scale GFET fabrication using a CVD-grown 
graphene layer and the detection of thrombin biomarkers [175]. Therefore, GFET-based thrombin 
sensing has the potential to be used as a point-of-care diagnostic device. However, for this to be 
used reliably in a real-world setting, the GFET must achieve the limit of detection, sensitivity, and 
analyte selectivity required for clinical use. As an example, thrombin concentration in blood can 
change from picomolar to micromolar range depending on the health condition. Therefore, a 
thrombin biosensor must exhibit a limit of detection in the picomolar level as well as a detection 
range up to a micromolar concentration [176]. 
 
In this work, we demonstrate that the aptamer-modified microfluidic GFET platform can 





analyses of the sensing performances as well as device characterization, including aptamer packing 
density and continuous real-time sensing, are presented. The GFET was fabricated using the CVD-
grown graphene transferred on prefabricated gold electrodes. In contrast to the mechanical 
exfoliation technique which yields higher quality of graphene, the CVD-based graphene allows 
large-scale production of graphene with controllable sensing area [148], [177]. Then, the GFET 
module was integrated with a microfluidic chip to build a miniaturized and portable biosensing 
module. The detection was performed by measuring the change in the Dirac voltage (∆VDirac). Our 
biosensor was able to detect thrombin with a concentration as low as 2.6 pM (~260 NIH 
microunits/mL), which is significantly lower than previously reported values [107], [178]. The 
binding affinity between the aptamer and the thrombin was quantified by calculating the 
dissociation constant which was confirmed by transient measurements in real-time. 
 
6.2. The Principle of Operation of the Microfluidic GFET-Based Biosensor 
Platform 
The working principle of the microfluidic thrombin biosensor is illustrated in Figure 6.1. Figure 
6.1A shows the schematic view of the integrated GFET device where a microfluidic channel with 
an inlet and an outlet traverses the source, drain and an in-plane gate electrode. Figure 6.1B depicts 
the three-electrode transistor device setup where the FET measurements were performed by 
applying a constant drain voltage (VDS) between the source and the drain, whereas a varying 
voltage (VGS) was applied on the gate. Figure 6.1C shows the mechanism by which target binding 
and detection is achieved. The Dirac voltage shifts either to the left or right depending on the type 
and concentration of the adsorbed charged species. If the adsorbed species are at low concentration 
or weekly charged, doping effect dominates while gating effect becomes dominant at high 
concentration or strongly charged species [79], [89]. In our experiments, while thrombin, which 
has an isoelectric point of around 9.5, was weekly and positively charged at pH 7.4 [165], [166], 
p-type doping was generated in graphene upon binding to the thrombin aptamer.  This p-type 
doping causes the Dirac voltage to shift in the positive direction [88]. By monitoring the shift in 






Figure 6.1.Conceptual illustration of the microfluidic GFET biosensor: (A) Schematic illustration 
of the integrated device; (B) GFET device setup with drain, source, and gate electrodes; and (C) 
The sensing mechanism based on surface charge-induced Dirac voltage shift (ΔVDirac) in the FET 
ID-VGS transfer characteristics curve.  
 
6.3. Materials and Methods 
6.3.1. Materials 
The aminated anti-thrombin DNA aptamers and the aminated anti-lysozyme aptamers (for control 
experiments in Appendix C) were purchased from Sigma-Aldrich. The aptamers were amine-
terminated with the following sequence:  
Anti-thrombin: 5՛–NH2–(CH2)6–CCA TCT CCA CTT GGT TGG TGT GGT TGG-3՛ [107].  
Anti-lysozyme: 5՛–NH2–(CH2)6–ATC AGG GCT AAA GAG TGC AGA GTT ACT TAG-3՛ 
[113]. 
Thrombin from human plasma was also purchased from Sigma-Aldrich. The protein stock 
solutions were prepared by dissolving the lyophilites in deionized water to achieve the different 
molar concentrations needed for the experiment and were stored at 4ºC. The diluted solutions for 
sensing experiments were prepared by adding 0.01×PBS (pH: 7.4) to the stock solution.  Since 





the Debye length from the graphene surface, it is critical to ensure that the Debye length be 
sufficiently large. For an effective GFET-based sensing, the Debye length should theoretically be 
comparable to the aptamer length [88]. In this work, the estimated length of the anti-thrombin 
aptamer is approximately 9.1 nm. While 1× PBS has a Debye length of 0.7 nm, the Debye length 
for 0.01× PBS is 7.3 nm [88], [179]. For this reason, 0.01× PBS was chosen as a running buffer 
for the electrical measurements. The CVD-grown graphene sheets were purchased from 
Graphenea Inc. as Easy Transfer Monolayer Graphene on a polymer film. 
 
6.3.2. Device Fabrication, Surface Functionalization, and Measurement Methods  
6.3.2.1. Device Fabrication 
For the fabrication of the FET devices, gold electrodes for the source, drain and gate contacts 
were patterned on a SiO2/Si substrate using conventional microfabrication techniques. Briefly, 
chromium (Cr, 5 nm) and gold (Au, 60 nm) films were thermally evaporated onto the substrate. 
Then the source, drain and gate contact regions were formed by standard photolithography, 
followed by wet chemical etching of Cr/Au layers. The Cr layer was used as an adhesion promoter 
between Au and SiO2. After the electrode fabrication, a 5 mm × 5 mm graphene film was 
transferred onto the electrodes (See Appendix C for details). 
 
The microfluidic channel with a dimension of 30 mm × 600 µm × 100 µm was fabricated 
with a polydimethylsiloxane (PDMS) block using the cast molding technique [180]. The inlet and 
the outlet of the channel were formed with metal tubing and the PDMS block was securely clamped 
to the GFET device. A photograph of the final integrated GFET module is shown in Figure 6.2A. 
The inlet and outlet of the device were connected with silicone tubes for analyte injection and 
removal. A motorized syringe pump (Harvard Apparatus) was used for driving the analyte 
solutions from syringes. Such a setup enables stable flow of the analyte solution and minimizes 
noise induced by liquid loading processes, as required for real-time, precise measurement of 






Figure 6.2. Device fabrication and graphene functionalization steps: (A) Photograph of the 
microfluidic-integrated GFET module (left) and the enlarged view of the source-drain electrodes 
of the right GFET array (right); and (B) Schematic illustration of the surface functional steps 
applied to the GFET devices before using it as sensors.  
 
The module consists of two GFET arrays, each array containing 3 GFET devices formed by 4 
equally spaced (50 µm gap) gold electrodes (100 µm wide) with two adjacent electrodes acting as 
the source and the drain. For the 3 GFET devices in each array, one in-plane gold electrode 
(approximately 6.0 mm spaced apart from the 4 electrodes) serves as the gate.  Table C1 
summarizes the labeling of the 6 GFET devices in the module.   
 
6.3.2.2. Surface Functionalization 
Prior to using the GFET devices as biosensors, the graphene surface was functionalized in several 
steps as shown in Figure 6.2B.  First, the graphene was treated with 10 mM 1-pyrene butyric acid 
N-hydroxysuccinimide ester (PBASE) solution in dimethyl formamide (DMF) delivered via the 
microfluidic flow system for 12 hours. The PBASE molecules were non-covalently coupled to the 





graphene and the pyrene functional group of PBASE [138].  The fluidic channel was then rinsed 
by flowing DMF, ethanol and DI water sequentially to remove any unbound PBASE. Next, 
aptamers were introduced into the channel by flowing a 2 µM aminated (at the 5ʹ-end) target 
specific aptamer solution and 0.1% (v/v) triethylamine (TEA) for a duration of 12 hours. The 
aptamers were covalently grafted to the surface bound PBASE molecules via amide bond 
formation resulting from reaction with the primary amine on the probe aptamer [173], [181]. 
Successful coupling of PBASE to graphene and aptamer to PBASE was confirmed by Raman, 
FTIR and UV-Vis analyses.  
  
6.3.2.3. Electrical Measurements 
All electrical measurements were performed on a Micromanipulator (450 PM-B) probe station 
using a PC-based LabVIEW program. A Keysight precision source/measure unit (B2902A) was 
used for biasing as well as for supplying input voltages and measuring the output currents. The 
drain-source voltage was maintained at 250 mV for all ID-VGS transfer curve measurements. The 
liquid-gate voltage was linearly scanned from 0 V to 2.5 V with a voltage step of 12.5 mV using 
the gate electrode. During each step, the VGS value was maintained for 1 second to stabilize ID to 
ensure reliability of ID-VGS transfer curves resulting a scan rate of 12.5 mV/s. All the measurements 
were performed with a fluid flow rate of 20 l/min. To evaluate the electrochemical effects on the 
GFET devices, the leakage current at the gate electrode was also measured. The leakage current 
IGS remained less than 1 µA and thus was considered negligible, as the magnitude of the ID was in 
the range of 800 µA.   
 
For the transient measurements of real-time monitoring of the aptamer-protein association and 
dissociation, ID was measured by keeping VDS = 0.1 V. The gate source voltage (VGS) was also 
fixed at a voltage near the charge neutrality point (i.e. VDirac) such that it locates in the linear region 
of the ID-VGS transfer curve yielding a high value of transconductance, gm (See Figure C2 in 
Appendix C). Here, the data points were collected once per second. Various concentrations of 
thrombin were injected at a flow rate of 20  l/min for 1 hour. Afterward, a 0.01×PBS buffer was 
flowed for another hour to dissociate and remove the bound protein biomarkers. Since GFETs can 
only observe changes in the charge density that occurs within the distance similar to the Debye 





6.4. Experimental Results and Discussion 
6.4.1. Characterization of the surface functionalization   
The interaction between PBASE and graphene via π-π stacking was characterized by Raman 
spectroscopy. For the sample preparation, the GFET device was functionalized with 10 mM 
PBASE in dimethyl formamide (DMF) for 2 hours followed by washing with DMF, ethanol and 
DI water. The Raman spectra for both the bare graphene and the PBASE-treated graphene are 
presented in Figure 6.3A.  The G- and 2D- bands in the spectra indicate the presence of graphene 
[182]. Moreover, the peak at 1618 cm-1 which is attributed to the pyrene group resonance peak due 
to the π-π stacking interaction [79], [88] between the aromatic rings of the pyrene group of PBASE 
and the basal plane of graphene which confirms the coupling of PBASE to graphene.  
 
To characterize the crosslinking of aminated aptamers with PBASE, both the aptamers and PBASE 
were reacted in a 3:2 mixture of tetrahydrofuran (THF) and PBS buffer. The aptamer-grafted 
PBASE was purified by column chromatography and was allowed to dry an oven at 45ºC for 8 h. 
The FTIR spectra of both dried PBASE-aptamer and pure PBASE powder are presented in Figure 
6.3B where the presence of a strong peak at 1653 cm−1 (C=O stretching in the amide I) and the 
broad stretching vibration peak around 3300 – 3550 cm−1 (N-H from the amide, O-H solely on the 
DNA) confirm the amide bond formation [183]. By contrast, the corresponding peak for C=O in 
PBASE appears at 1725 cm−1 and the absorption peaks at 1785 cm−1 and 1816 cm−1  are related to  
the symmetric and asymmetric stretching vibration of the two C=O groups in the imide, while the 
stretching peak for C-N in the imide appears at 1375 cm−1 .  
 
After the PBASE and aptamer crosslinking was confirmed, the PBASE functionalized GFET 
device was exposed to a 2 µM aminated (at the 5ʹend) target specific aptamer solution for 12 hours. 
The sample was then washed with DI water and dried followed by UV-Vis spectroscopy 
measurements. The UV-Vis absorption spectroscopy is shown in Figure 6.3C where the absorption 
peak at around λ = 260 nm is a characteristic peak of the DNA oligonucleotides. This proves 






Figure 6.3. Characterization of linking of aptamer to GFET: (A) Raman spectrum (excitation by 
532 nm) showing the coupling of PBASE to graphene; (B) FTIR spectrum showing the covalent 
binding of aminated aptamer with PBASE; (C) UV-visible spectrum showing the final aptamer 
crosslinking to PBASE/graphene; and (D) ID-VGS transfer characteristics showing the effects of 
surface functionalization of the graphene.  
 
We further investigated the functionalization-induced doping by measuring the ID-VGS transfer 
curves of the microfluidic-GFET device before and after PBASE coupling. As can be seen from 
Figure 6.3D, immobilizing PBASE linker to graphene causes the Dirac voltage to shift right. This 
shift in the positive direction can be explained by the p-type doping effect due to the charge transfer 
between PBASE and graphene [79], [88]. It is important to note that while the pyrene group of 
PBASE is electron-rich and not expected to induce p-type doping to the graphene, the carbonyl 





to the linker molecule [173], [184]. After PBASE functionalization, the devices were further 
modified with DNA-based aptamer which caused the Dirac voltage to shift left with respect to the 
position after the PBASE modification step. This is due to the n-type doping of graphene channel 
by the electron rich nucleotide bases of the DNA aptamers acting as electron donors when 
interacting with graphene [141], [142]. Using the shift in Dirac voltage, the aptamer density was 
estimated to be 1.427 × 1011 /cm2 which is equivalent to 23.2 nm aptamer probe spacing (See the 
Supplementary Information for the detailed calculation). 
 
6.4.2. The FET-Based Sensing Experiments 
6.4.2.1. Control Experiments 
To examine the inertness of the bare graphene to thrombin, a set of control experiments were 
performed by exposing bare graphene to thrombin solution of various concentrations. As shown 
in Figure C1(A) in Appendix C, no significant shift in the Dirac voltage is observed indicating a 
non-responsive behavior of bare unmodified graphene to thrombin. We also performed another set 
of control experiments to examine the adsorption behavior of thrombin on GFET device modified 
with a different aptamer sequence. In this case, the graphene was modified with anti-lysozyme 
aptamers and were exposed to different concentrations of thrombin solutions. The measured 
transfer curves are presented in Figure C1 (B) which shows that there is no significant shift in the 
Dirac voltage, indicating negligible non-specific adsorption of thrombin protein during the sample 
flow.   
  
6.4.2.2. The Effects of Analyte Concentration on the Dirac Voltage Shift 
Following the functionalization and aptamer immobilization, the GFET devices were exposed to 
different concentrations of thrombin by delivering them through the microfluidic channel at 20 
µl/min for 45 minutes each. Each sample exposure was followed by a washing step with 0.01×PBS 
buffer for another 45 minutes for sensor regeneration. Figure 6.4A shows the ID-VGS characteristics 
of the developed biosensor after exposure to different concentrations of thrombin protein. 
Exposure to 1 pM of thrombin caused a Dirac voltage shift (ΔVDirac) of 101 mV in the positive 
direction with respect to VDirac = 934.4 mV at 0 pM thrombin. With increasing concentrations of 
the thrombin biomarker, VDirac continues to shift further to the right until it begins to saturate at 





neutral pH [165], [166]. Upon binding of the thrombin to the anti-thrombin aptamer, the net 
positive charge of the protein causes p-type doping of the graphene which explains the right-shift 
of the Dirac voltage [27]. Figure 6.4B depicts the concentration dependent calibration curve 
obtained by plotting the Dirac voltage shift (ΔVDirac) relative to the zero concentration of the 
analyte (0 pM Thr). As indicated by the error bars in Figure 6.4B, fabricating reproducible GFET 
devices is a challenge. This is primarily due to the variations in the graphene sheet in terms of the 
graphene channel area as well as the defects and grain boundaries which can all have a significant 
impact on the electronic properties of the film. However, the device reproducibility can be 
improved by directly growing and patterning the graphene on the substrate rather than transferring 
the film manually. 
 
Figure 6.4. Performance of the microfluidic-integrated GFET biosensor: (A) ID-VGS transfer 
characteristics of the GFET biosensor after exposure to different concentrations of thrombin 





(R2=99.25%). The sample set is 𝑛 = 3 and the error bar represents 1 standard error; (C) ID-VGS 
transfer characteristics of the GFET thrombin biosensor after exposure to different concentrations 
of lysozyme protein; and (D) Comparative bar chart showing the ΔVDirac of the GFET thrombin 
sensor after exposure to different concentration of thrombin and lysozyme protein.   
 
The calibration curve profile is best fitted by a model adapted from the Hill-Langmuir equation 
that describes the equilibrium binding of a ligand by a receptor [137], [185], [186]: 
∆𝑉𝐷𝑖𝑟𝑎𝑐 =










where 𝑉0 is the estimated minimum response with all binding sites empty, 𝑉𝑚 is the estimated 
maximum response with all the binding sites occupied, 𝑥 is the target concentration, 𝐾𝐷 is the 
effective dissociation constant that represents the concentration at which half of the available 
binding sites are occupied, and 𝑛 represents the Hill coefficient.  
  
The best fit (R2 = 0.9925) values are summarized in Table 6.1, where the Hill coefficient value of 
n = 0.386 being less than 1 indicates a negative cooperativity in the binding of thrombin to the 
GFET biosensor that may be due to the protein-protein interactions upon binding or increased 
charge carrier scattering with increased ligand binding [137], [154]. The best fit value of KD = 
375.8 ± 165.6 pM is in the similar range as reported previously [175], [187]. Based on the obtained 
calibration curve, the calculated limit of detection (LOD) of our sensor is 2.6 pM (See Appendix 
C for details). 
 





















6.4.2.3. Selectivity of the GFET Biosensor 
The selectivity of the biosensor was tested against another common protein biomarker lysozyme. 
For this experiment, the GFET device functionalized with thrombin-binding aptamer was exposed 
to various concentrations (1, 10, 100, and 1000 nM) of lysozyme in 0.01× PBS buffer through the 
microchannel and incubated for 45 minutes. The measured ID-VGS characteristic curves are 
presented in Figure 6.4C. A comparative bar chart showing the Dirac voltage shift for both 
thrombin and lysozyme is shown in Figure 6.4D. Exposure to high concentrations of lysozyme 
does cause some degree of Dirac voltage shift possibly due to the protein either nonspecifically 
binding to the anti-thrombin aptamer or directly adsorbing to the graphene surface. In either case, 
the positively charged lysozyme [96] affects the doping level of the GFET (i.e. p-type doping) in 
the same way the thrombin does to the device. However, its effect is relatively small compared to 
that of thrombin of the same concentration, as shown in the chart. 
 
6.4.2.4. Real-Time and Transient Measurements 
The transient FET measurements were performed on the device to monitor the protein-aptamer 
interaction in real-time. Various concentrations (0 pM – 1 µM) of thrombin in 0.01× PBS were 
added to the sensor for 1 hour. To check the selectivity of the sensor, the GFET was also tested 
against a high concentration (1µM) of lysozyme for the same amount of time period. The signal 
ID (t) was recorded while keeping VGS and VDS constant. The time-dependent measurements are 
shown in Figure 6.5A. A gradually drifting background signal has been subtracted from ID (t). It 
can be seen that for each concentration of thrombin exposure, ID (t) follows an exponentially 
decreasing profile until PBS washing buffer was introduced to dissociate and remove the bound 
thrombin. The figure also shows that there is minimal change in ID when exposed to lysozyme.  
Figure 6.5B shows the enlarged view of the association and dissociation curves for the 1µM 
thrombin concentration. After analyte injection into the microfluidic device, it took approximately 
15 minutes for ID (t) to respond due to the time required for the liquid to reach the GFET. As soon 
as the analyte reaches the sensor, target binding occurs and the signal drops exponentially until it 
reaches a steady-state approximately after 35 minutes. The amount of drop (∆ID) in the drain-
source current is plotted against the thrombin concentrations that result in the current calibration 
curve in Figure C3 in the Appendix C. Table C2 in Appendix C summarizes the best fit (R2 = 





corresponding dissociation constant is found to be KD = 731.7 pM which is comparable to the 
value obtained from the voltage calibration curve. 
 
Figure 6.5. (A) The continuous real-time measurements of the GFET biosensor. The plot depicts 
the transient measurement of the microfluidic-integrated GFET module biosensor. The liquid gate 
was fixed at VGS = 0.75 V while the drain-source voltage was maintained at VDS = 100 mV. A 
constant flow rate of 20 µl/min was maintained throughout the experiment. Data points were 
collected every 1 second. A baseline drift of 9.378 nA/min has been subtracted from the curve. 
Sharp spikes around the introduction of thrombin and the PBS buffer are noises associated with 
switching of the syringes; and (B) Binding and unbinding process for the thrombin with 
concentration of 1µM.  
 
 The selectivity of the sensor towards thrombin was again confirmed from this experiment as 
introducing 1 µM lysozyme did not cause any significant change to the ID (t) signal. The sensor 
can also be regenerated by simply rinsing with PBS buffer which has been confirmed by the 
unbinding process and the baseline curve returning to the initial value to approximately 525 µA 
shown in Figure 6.5B.  
 
When recording the ID (t) measurement, the raw data exhibits a gradual upward drift over time. 
This slow increase in the baseline current can be explained by the possible dissociation of pyrene 
anchors from the graphene surface resulting in a loss of aptamers from the GFET [175]. This loss 









. In our devices, the measured baseline drift was ∆𝐼𝐷 = 9.378 nA/min which 
corresponds to a ∆𝑉𝐺𝑆 changing at a rate of 202 µV/min. At this rate, 50% of the aptamer coating 
would dissociate after approximately 10 hours (i.e. the time to shift ∆𝑉𝐺𝑆 = 117 mV) which is 
similar to the previously reported value [175]. The measurements in Figure 5 are the result after 
baseline correction by subtracting the current drift. 
 
6.5. Conclusion 
In conclusion, in this work, we have developed a microfluidic-integrated miniaturized GFET 
biosensor module for selective detection of thrombin biomarker. Thrombin is often used as a model 
protein in protein biosensing. It is also known for its several biomedical significances such as its 
critical role in hemostasis and thrombosis, involvement in several cardiovascular diseases and 
regulation of tumor growth. The binding affinity of the protein-aptamer interaction was quantified 
with a dissociation constant value of 375.8 pM which was further confirmed by real-time thrombin 
detection measurements. We also characterized the functionalization of aptamers on the GFET 
surface by Raman, UV-Vis and FTIR spectroscopy techniques. The sensor is able to detect 















 A FLEXIBLE PRINTED GFET FOR REAL-
TIME MONITORING OF IL-6 PROTEIN 
 
7.1. Introduction  
Graphene FET-based devices have proven to be very convenient for highly sensitive detection of 
biomarkers as described in Chapter 5 and 6. Moreover, due to the planar structure with flexibility, 
GFETs are highly suitable for flexible biosensors. In this chapter, I will describe how GFETs can 
be fabricated on polymer based flexible substrates and demonstrate real-time detection of IL-6 
protein, a well-known cytokine and a biomarker for immune responses, as a representative target 
analyte [188], [189].  
7.2. Flexible GFETs in wearable electronics 
Wearable electronics are usually flexible devices that can be worn or mated with human skin to 
continuously and closely monitor an individual’s activities, without interrupting or limiting the 
user’s daily routine. Therefore, wearable biosensors could enable real-time continuous monitoring 
of an individual’s physiological biomarkers, that are essential to the realization of personalized 
medicine for a variety of chronic and acute diseases [190], [191]. Essentially, wearable biosensors 
should be designed in a manner so that it avoids the painful and risky blood sampling procedures 
and can easily blend in with the user’s daily routine. This can be accomplished by providing a 
direct contact between the biosensing platform and the biofluids (sweat, tears, saliva and interstitial 
fluid) without inducing discomfort to the users [192].  
 
Wearable biosensors have garnered substantial interest over the past decade, mainly concentrated 





vital signs (such as heart rate, blood pressure, skin temperature, etc.) and fail to provide insight 
into the user’s health state at molecular levels. However, chemical analysis of biofluids could 
enable such insight because it contains physiologically and metabolically rich information that can 
be retrieved non-invasively. Sweat analysis is currently used for applications such as disease 
diagnosis, drug abuse detection, and athletic performance optimization [190], [191]. It is the most 
easily accessible biofluid for chemical sensing applications since sweat glands are distributed 
across the entire body, with more than 100 glands/cm2 [192]. It is rich in physiological data, 
containing electrolytes (such as sodium and potassium ions) and metabolites (such as lactate and 
glucose). Under most climate conditions, an average adult human secretes between 500 to 700 ml 
of sweat per day [193]. Therefore, sweat-based sensors can be applied in a variety of biomedical 
and fitness applications.  
 
Wang et al. from the Lin group of Columbia University developed an ultra-flexible and stretchable 
GFET-based aptasensor for sensitive detection of TNF-α biomarker [194]. Presented in Figure 7.1, 
this flexible GFET biosensor, which was built on Mylar substrate, demonstrated a high level of 
mechanical flexibility and durability, as well as highly consistent electrical properties and 
biomarker responses. However, the electrodes were deposited with metal evaporation and 
patterned with conventional photolithography, thus making the fabrication process expensive and 
complex. Moreover, sophisticated cleanroom environment and trained personnel are required for 
the microfabrication of the GFET devices. All these issues can be addressed by printing the 
electrodes using commercially available silver ink. Printing offers numerous advantages compared 
to the microfabrication, such as flexibility and versatility in patterning, low-cost, rapid and mass 





to print commercially available conductive silver ink on a flexible substrate and transfer graphene 
on this printed electrode resulting in a printed flexible GFET. With this printed flexible GFET, 




Figure 7.1. Ultra-flexible and stretchable GFET biosensor on flexible substrate. (a) Schematic of 
the flexible device; (b) photographs of the ultra-flexible sensor conformably mounted on human 
hand; (c) photograph of the nanosensor placed on a glass slide for biomarker detection; and (d) 
Transfer characteristic curves measured when the nanosensor was exposed to TNF-α solution with 
different concentrations. Reprinted from [194].    
 
7.3. Kapton® as flexible substrate for GFETs 
Materials properties that are critical for a substrate in MEMS-based applications are the chemical 





processes, such as physical deposition and etching require flexible substrate to experience high 
temperature stress and vacuum. Cleaning agents such as acetone, isopropyl alcohol, or organic 
solvents such as dimethyl formamide (DMF) are often used in photolithography and surface 
functionalization of graphene FET based devices. Commonly used polymers used as flexible 
substrates, such as poly(dimethylsiloxane) (PDMS), polyethylene terephthalate (PET) or 
polyethylene naphthalate (PEN) can be vulnerable to these solvents. Polyimides can address these 
issues due to their superior properties [196] as described below: 
• High thermal stability (up to 300ºC) 
• Highly chemical stability against commonly used solvents in the device processing 
• Low outgassing under high vacuum  
• Young’s modulus of 4GPa 
 
Among other polyimides, Kapton® is selected as the flexible substrate because of its wide 
availability. It is commercially available both in roll and in sheet format with standard thickness 
of 0.0254 to 0.127 mm as seen in Figure 7.2. 
 
 
Figure 7.2. Kapton® as a flexible substrate.  
7.4. Materials and Methods  
7.4.1. Materials 
The aminated aptamers having the specific affinity to mouse IL-6 (#ATW0077, KD=5.4 nM) and 
the resuspension buffer were purchased from Base Pair Biotechnologies, Inc. (TX, USA). The 





specific toward IL-6 proteins. IL-6 recombinant mouse protein was purchased from BioLegend 
(San Diego, CA). PBASE (1-pyrenebutyric acid N-hydroxysuccinimide ester) was purchased from 
Santa Cruz Biotechnology (TX, USA). Kapton® film (size: 12 inches × 12 inches, thickness: 1 
mil) was purchased from Amazon.com, Inc.  
 
7.4.2. Manufacturing of the printed GFET 
The manufacturing of the printed GFET is presented in Figure 7.3. the manufacturing of the printed 
GFET starts with designing the electrode pattern in an open-source CAD software KiCAD and 
then printing it on a Kapton® film using Voltera V-One printer. Conductive silver ink was used 
for printing the electrodes. Following printing, the printed film was sintered on a hotplate in order 
to improve the adhesion between the ink and the film. Once the printed electrodes are sintered,  
 
Figure 7.3. Manufacturing of printed GFET on Kapton® substrate. 
a monolayer graphene film was transferred on the electrodes using a method known as “fishing.” 
The transfer method was described in Figure 5.2 of Chapter 5. After the transfer, the protective 
PMMA layer on top of graphene was removed by acetone and ethanol. The printed GFET device 
on Kapton film with graphene transferred on it is shown in Figure 7.4. A PDMS microfluidic 






Figure 7.4. Printed GFET on Kapton®: (A) photograph showing the flexibility of the printed 
GFET, and (B) enlarged view particularly showing the graphene monolayer transferred on the 
electrodes.  
7.4.3. Functionalization of the printed GFET 
After manufacturing, the printed GFETs were functionalized with target (IL-6) specific aptamers 
for using them as sensors. The functionalization process is schematically illustrated in Figure 7.5 
where amine-linked aptamers are anchored on GFET using the PBASE linker via the well-
known NHS crosslinking reaction. The details have been described in Chapter 6.  
 
 
Figure 7.5. Schematic showing the functionalization steps of the printed GFET. 
 
7.5. Experimental Results and Discussion 
7.5.1. Characterization of the surface functionalization 
The functionalization steps were characterized electrically using the GFET measurements. The 





trend as our previous GFET devices on solid (SiO2/Si) substrate described in Chapter 6. This 
demonstrates a successful functionalization of aptamers on the printed GFET on Kapton®.  
 
Figure 7.6. Electrical characterization of the GFET functionalization: (A) ID-VGS transfer 
characteristics curve at each functionalization strep, and (B) the bar graph showing the values of 
VDirac for each functionalization step.  
7.5.2. Real-time sensing of IL-6 using printed GFET 
After successful functionalization of the printed Kapton GFETs (k-GFETs), they were utilized for 
real-time sensing of IL-6 protein. For the real-time measurement, the GFET was biased at VGS = 
100 mV and VDS = 750 mV. The binding between the aptamers and the proteins was monitored by 
recording the changes in IDS while different concentrations (1, 10, 100 nM) of IL-6 protein in 0.01x 
PBS+1mM MgCl2 were added to the sensor for 10 min each followed by a buffer incubation step 
for sensor regeneration. The real-time measurements are presented in Figure 7.7. It can be seen 
from Figure 7.7 that upon exposure of IL-6 protein, IDS decreases due to the association of the 
aptamers and the target proteins. Moreover, when the buffer is introduced, IDS returns close to its 







Figure 7.7. Real-time monitoring of IL-6 buffer: (A) transient measurements showing binding 
and unbinding of aptamer-target, and (B) concentration dependent calibration curve.  
7.6. Conclusion 
In this chapter, the feasibility of using Kapton® substrate based printed GFET for sensing of 
protein biomarkers has been demonstrated. The electrodes were printed using a benchtop PCB 
printer which makes the production easy, rapid, and low-cost enabling their use in point-of-care or 
low-resources setting. Moreover, the use of Kapton® makes it compatible with wearable 



















 AN ORGANIC SOLVENT-FREE 
APTAMER IMMOBLIZATION METHOD ON GFET 
PLATFORM 
8.1. Introduction  
In recent years, graphene-based field-effect transistors (GFETs) and their uses as sensing platforms 
have been greatly successful in developing various microfluidic and lab-on-a-chip-based 
biosensors [197], [198]. Their effectiveness as a biosensing platform can be attributed to their high 
carrier mobility, sensitivity to molecules, and 2-dimensional geometry resulting in ultra-sensitivity 
and easy integration capability [199]–[201]. A GFET works based on the modulation of the 
graphene channel conductance (i.e., the channel current) between the source and the drain upon 
the application of an external electric field through the gate electrode. This principle can be 
exploited as a method for sensing of biomolecules since charged molecules that are in close contact 
with graphene (within the Debye length) will cause a change in the electric field leading to a 
modulation in the drain-source current (IDS) of the GFET. A significant difference between GFETs 
and other conventional FETs is their ambipolar transfer (IDS – VGS) curve which causes a minimum 
channel current at the Dirac voltage also known as the charged neutrality point (VCNP). Any change 
in the electric field induced by the adsorption of the charged molecules at the graphene surface 
essentially causes a shift in the charge neutrality point enabling GFETs to be used for ultra-
sensitive detection of the target biomolecules [200], [202].  
 
To enhance selectivity in analyte detection, GFETs are commonly integrated with bioreceptors 
such as aptamers, antibodies and so forth. In this work, aptamers are used as the representative 
target recognition probes. A major part of the implementation of such aptameric GFET devices is 
the reliable immobilization of aptamer probes onto the graphene channel of the device. In general, 
there are two main strategies for functionalizing aptamers on graphene, namely, the covalent and 
the non-covalent immobilization approaches. While the covalent approaches offer certain 





altar the physical properties of graphene. Hence, non-covalent modifications have been frequently 
used in order to maintain the inherent properties of pristine graphene [203]. A typical non-covalent 
attachment of aptamers on graphene involves a two-step method as shown in Figure 8.1A. In the 
first step, a pyrene is anchored on the graphene via the π-π stacking interaction and in the second 
step, the amine-terminated aptamers are attached to the pyrene via the EDC/NHS (1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride/N-hydroxysuccinimide) crosslinking 
chemistry [204].  
 
Figure 8.1. A schematic illustration of (A) a two-step aptamer functionalization on graphene 
requiring the use of organic solvents to dissolve and disperse PBASE (1-pyrenebutyric acid N-
hydroxysuccinimide ester), and (B) the proposed one-step modification process of aptamer probes 
on GFET (Inset: the crosslinking of PBASE with an aminated aptamer to form a pyrene-tagged 






A commonly used pyrene-based crosslinker, such as PBASE (1-pyrene butyric acid N-
hydroxysuccinimide ester) as shown in Figure 8.1, requires organic solvents such as Dimethyl 
formamide (DMF) or Dimethyl sulfoxide (DMSO) in order for it to be well-dispersed in a solution. 
However, such solutions, being strong polar aprotic solvents, can dissolve most organic 
compounds [205] and can become an issue for a number of applications especially in lab-on-a-
chip and point-of-care diagnostic platforms [206]–[208]. Such devices often utilize thermo 
plastics, flexible polymers, and passivation layers that are vulnerable to organic solvents resulting 
in fluid leakage and other irreversible damages. Therefore, to circumvent these challenges, an 
organic solvent-free aptamer immobilization method would be highly desirable and would also 
allow more flexibility in choosing the materials in device fabrication. In this chapter, I explore the 
feasibility of using an organic solvent-free aptamer functionalization technique where the amine-
linked DNA aptamers are pre-tagged with pyrene groups. These pyrene-tagged DNA aptamers 
(PTDA) are easily soluble in an aqueous buffer and can be anchored onto graphene surfaces 
(Figure 1B) without the need of organic solvents. Wu et el. reported a GFET-based biosensor for 
selective detection of E. Coli with the aid of pyrene-tagged DNA aptamers [83]. In their work, the 
pyrene was incorporated during the synthesis process of the aptamers and the purification of the 
aptamers was also conducted using column chromatography. Another GFET-based biosensor was 
developed by Farid et al. for the detection of tuberculosis biomarker IFN-𝛾 using pyrene tagged 
aptamers [209]. However, the aptamers were dissolved in DMF for diluting and immobilization 
on GFET surface. Inspired by the previous developments, I propose in this work a cheaper and 
simpler method to pyrene conjugation of the aptamers. Although pyrene conjugation on the 
terminal of oligonucleotides has been well-established [210], the main novelty of this work is in 
the use of such pyrene-tagged aptamers in the development of GFET-based protein biosensor. 
Here, I demonstrate that GFET-based biosensors developed using aptamers pre-conjugated with 
pyrenes are also effective in protein biomarker (IL-6) detection. In our approach, the PTDAs are 
formed by crosslinking the pyrene groups to the commercially available amine-terminated 
aptamers. Furthermore, to separate out the unreacted pyrenes, a simple purification is performed 
by precipitation with the help of a centrifuge. Following the synthesis, the pyrene-tagged aptamers 
are anchored onto the graphene surface. Moreover, the efficiency of the immobilization is 
enhanced by applying an external electric field (E-field) to the GFET through the gate electrode 





the amount of the PTDAs anchored on the graphene surface is limited by the rates of diffusion and 
mass transfer (Figure 8.2A (left)). However, by applying a negative electric field, the PTDA 
molecules, which are negatively charged due to the combined effects of the electron-rich pyrenyl 
groups and the negatively charged DNA strands, are pushed towards the graphene surface where 
they interact with the graphene through the formation of π-π stacking interaction thereby enhancing 
the immobilization rate and the surface coverage (Figure 8.2A (right)). This one-step 
functionalization method also eliminates the need for additional washing steps and thus reduces 
the time required for device fabrication. To demonstrate the effectiveness of our new technique in 
GFET-based biosensor implementation, the developed platform is used to detect interleukin-6 (IL-
6) protein, a well-known cytokine and biomarker for immune responses, as a representative target 
analyte [188], [189].  
 
Figure 8.2. Schematic illustration showing the effect of applying an external electric field during 





and with the external electric field, and (B) device setup for applying the external E-field during 
the PTDA functionalization on GFET.  
 
8.2. Materials and Methods  
8.2.1. Materials 
The aminated aptamers having the specific affinity to mouse IL-6 (#ATW0077, KD=5.4 nM) and 
the resuspension buffer were purchased from Base Pair Biotechnologies, Inc. (TX, USA). The 
aptamer’s affinity has been thoroughly characterized by the manufacturer and is shown to be 
specific toward IL-6 proteins. The predicted secondary structure of the aptamer sequence is 
presented in Figure 8.3A. PBASE (1-pyrene butyric acid N-hydroxysuccinimide ester) was 
purchased from Santa Cruz Biotechnology (TX, USA). The GFET chip (GFET-S20) fabricated on 
SiO2/Si was purchased from Graphenea, Inc. (San Sebastian, Spain). The gold electrodes 
(source/drain) were passivated with insulating layers consisting of Al2O3 (50 nm)/Si3N4 (100 nm) 
surrounding the electrode/graphene interface. A polydimethylsiloxane (PDMS) well (3 mm 
diameter) was then integrated in-house to contain the liquid gate on the passivated area of the 
electrode as well as to reduce liquid evaporation during measurements and incubation steps. Figure 
8.3B, C shows the image of the GFET chip consisting of 12 individual GFET devices with a PDMS 






Figure 8.3. (A) Predicted secondary structure of the aptamer sequence purchased from Base Pair 
Biotechnologies, Inc. (Product # ATW0077) and the photographs of (B) the GFET chip (12 
individual GFETs per chip) with PDMS well on top; and (B) the enlarged view of the 3 GFET 
devices of the chip (without the PDMS well). The source and drain electrodes are passivated with 
an insulating layer while the in-plane gate electrode is fully exposed.  
8.2.2. Formation of pyrene-tagged DNA aptamer (PTDA) probes 
The crosslinking of the pyrene groups to the aptamers to form PTDAs is achieved by incubating 
the aminated aptamers with PBASE dissolved in DMF following the protocol provided by the 
aptamer manufacturer [211]. Briefly, 50 µL of 100 µM IL-6 binding amine-linked (at the 5՛ end) 
aptamer in amine resuspension buffer is mixed with 1.26 µL of 10 mg/mL PBASE for 1 hour in 
the dark. Then, 5 µL of 3 M sodium acetate is added to the aptamer/PBASE mixture followed by 
the addition of 125 µL cold ethanol (100%). The mixture is then placed in the freezer for 25 
minutes followed by centrifugation at 13000 RPM for 15 minutes causing a pellet formation as a 
precipitate. The precipitate is collected by decanting the supernatant and then washed with 70% 





datasheet, the conjugation efficiency of the protocol varies from 50%–90%. Although the pellet is 
expected to contain a very high yield of conjugated PTDAs, it also includes some unconjugated 
aptamers or PBASE which can negatively impact the sensor performances. Also, there is the 
possibility of multi-conjugated aptamers due to the interaction with amine groups in the 
nucleobases. To obtain a precise yield of successful conjugation between aptamers and PBASE, a 
more time-consuming analytical tools such as high-performance liquid chromatography (HPLC) 
could be used to experimentally investigate the conjugation efficiency. 
 
The concentration was determined by obtaining UV-Vis spectra measured with a Nanodrop 
spectrophotometer. Figure D1 (Appendix D) shows the UV-Visible spectrum of the resuspended 
PTDA. The peak at 260 nm corresponds to the presence of DNA nucleobases in the solution [212]. 
Although the UV-Vis spectrum is not able to provide the qualitative information about the 
aptamers (i.e., whether it is denatured or intact) we anticipated that the majority of the aptamers 
are in the properly functioning condition as evidenced by our GFET measurement results. 
Afterwards, the PTDA solution was stored at 4 °C. 
 
8.2.3. Immobilization of PTDA on graphene 
For GFET functionalization and measurements, a PDMS well was constructed over graphene to 
avoid evaporation of liquid. The solution containing PTDAs (2 µM in 0.01x PBS) was loaded into 
the well and a negative electric field (-400 mV) was applied to the solution using a wire inserted 
into the PTDA solution for 4 hours as shown in Figure 8.2B. Then, the GFET device was rinsed 
with DI water to remove any unbound PTDA probes.   
 
8.2.4. Selective detection of IL-6 protein 
After functionalizing the GFETs with IL-6 binding aptamers, various concentrations (0.1, 1, 10, 
and 100 nM) of IL-6 protein in 0.01x PBS with 2 mM MgCl2 was exposed to the sensing area for 
10 minutes. To investigate the selectivity and specificity, 100 nM of lysozyme (Lys) protein was 
also exposed to the IL-6 aptamer modified GFET in the same buffer.  
 
8.2.5. Electrical measurements 





PM-B) and a Keysight B2902A source/measure unit (SMU) is used to measure the ID–VGS transfer 
characteristics. Voltage control and data acquisition are performed using a LabVIEW program. 
During the measurement, the drain–source voltage (VDS) is biased at 100 mV and the drain current 
(ID) was read while the liquid–gate voltage (VGS) was linearly scanned from 0 V to 1 V with a 
voltage step of 12.5 mV using the in-plane gold gate electrode. A scan rate of 12.5 mV/s was 
maintained so that ID is stabilized to ensure reliable measurements of the ID–VGS transfer curves. 
 
8.3. Results and Discussion 
8.3.1. Characterization of device performance and effect of gate materials 
8.3.1.1. Mobility calculation of the GFET devices 








 is the width-to-length ratio of the GFET channel, 𝑪𝑻𝑮 is the total gate capacitance of the 
liquid gate, 𝝁 is the carrier mobility. Figure 8.4A shows the ambipolar transfer characteristics of a 
GFET resulting in a V-shaped curve where the left branch represents the increasing density of 
positive charge carriers (holes) and the right branch represents the increasing density of negative 
charge carriers (electrons) [214]. The critical transition voltage between the two regions where the 
current reaches a minimum is called the charge neutrality point (VCNP) or the Dirac voltage (VD) 
[215]. The slope of the transfer curve (
𝒅𝑰𝑫𝑺
𝒅𝑽𝑮𝑺
) in each region indicates the transconductance (𝒈𝒎) 
for the hole and the electron, respectively and can be calculated by measuring the slopes of each 
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Therefore, the average carrier mobilities for holes and electrons were calculated to be: 𝝁𝒉 =
𝟏𝟗𝟐𝟎 ± 𝟔𝟏 cm2/V/s and 𝝁𝒆 = 𝟐𝟒𝟕𝟓 ± 𝟏𝟔𝟑 cm





was taken to be 1.65 µF/cm2 [217]. This high values of the carrier mobilities indicate the suitability 
of the GFETs for sensing applications.   
 
Another important parameter that affects the sensitivity of the GFET devices is the on-off ratio 
(ION/IOFF) of the drain-source current. The larger the value of the on-off ratio, the better the 
sensitivity of the GFGET since the device will exhibit better immunity to noises. An on-off ratio 
value of ~8 is calculated for the used devices which is above average for GFET devices grown by 
a CVD technique [215].  
 
7.3.1.2. Effect of gate materials on device characteristics  
I also investigate the effect of different gate materials (Pt, Au, and Ag/AgCl) on the GFET transfer 
characteristics illustrated in Figure 8.4B, C, D.  Figure 8.4B shows the effects of the three gates 
on the Dirac voltage or the charge neutrality point (VCNP) for the 6 GFET devices on a single chip. 
As seen in the figure, Ag/AgCl gate electrode gives the lowest VCNP among the three gate 
electrodes. However, the gold electrode provides the lowest device-to-device variations among the 
devices on a single chip.   
 
Figure 8.4C shows the effect of gate materials on gate leakage current where each bar represents 
the RMS value of the leakage current (IGS) calculated from the IGS-VGS curves (See Appendix D). 








Where, 𝒏 is the number of measurement points, and 𝒊𝑮𝑺 is the leakage current for each individual 
gate voltage.  
 
Gate leakage has been a very common phenomenon in liquid-gate GFETs and is primarily caused 
by the electrochemical redox reaction at the graphene/liquid interface resulting in an increased 
current flow that negatively impacts the sensing performances of a sensor. Though passivation of 
exposed electrodes can reduce the leakage current, carbon clusters and photoresist residues during 





scans [218], [219]. Among the three gate materials tested, Ag/AgCl results in the lowest gate 
leakage.  
 
Figure 8.4D shows the effect of gate materials on the hysteresis of GFET transfer characteristics. 
Gate hysteresis or simply, hysteresis in GFET is the deviation of drain-source current upon reversal 
of the gate voltage sweep direction [220]–[222].  This causes a shift in the charge neutrality points 
in the forward and backward scans (See Appendix B). This shift (ΔVCNP,h) has been plotted in 
Figure 8.4D for the three gate materials. It can be seen that Ag/AgCl gives the lowest hysteresis. 
 
Though Ag/AgCl demonstrates the best performance in terms of operating voltage, gate leakage 
and gate hysteresis, in-plane gold electrode is used throughout the experiments as it gives the 
highest uniformity of the charge neutrality point among the devices on a single chip. Moreover, 
the in-plane configuration of the gold electrode which can be fabricated at the same lithography 
step as the golden source and drain electrodes enhance the compactness of the setup and allows 






Figure 8.4. Characterization of GFET device performances and effect of gate materials. (A) GFET 
transfer curve showing the calculation of transconductance, and bar charts showing the effect of 
gate materials on (B) VCNP, (C) leakage current (rms value), and (D) gate hysteresis.  
 
8.3.1.3. Characterization of successful functionalization of GFETs 
The synthesized PTDAs were first characterized to verify the presence of an amide bond between 
the PBASE and the aminated aptamer. The amide bond was characterized using the Fourier-
transform infrared (FTIR) spectroscopy as presented in Figure 8.5A, where the presence of a strong 
peak at 1653 cm−1 (C=O stretching in the amide I) and the broad stretching vibration peak around 
3300–3550 cm−1 (N–H from the amide, –OH group at the 3ʹ end of the DNA) confirm the amide 
bond formation [204]. Although amine groups from adenine, cytosine, guanine can also react with 
the NHS ester of the PBASE linker resulting in amide bond, this efficiency of these reactions are 
quite low compared with that with the primary amine group connected at the 5՛ end of the DNA 
aptamer. Hence, it is expected that the amide peak at the FTIR is primarily attributed to the amide 







Figure 8.5. Optical characterization of the one-step functionalization of aptamer probes on 
graphene. (A) FTIR characterization of the amide bond of PTDA in dry state, and (B) Raman 
spectrum (excitation by 532 nm) of three spots of PTDA functionalized graphene along with that 
of a blank graphene (Gra).  
 
After the amide bond was confirmed by the FTIR spectroscopy, the PTDAs were immobilized on 
a bare graphene. The presence of the PTDAs on graphene was confirmed by Raman spectroscopy. 
For Raman measurements, two samples were prepared, a blank graphene and a graphene 
functionalized with PTDAs. The Raman spectra for the PTDA-modified graphene was taken at 3 
different spots on the surface. Figure 8.5B shows the Raman spectra of the blank and the PTDA-
functionalized graphene where the G-band split at around 1628 cm-1 indicates the anchoring of the 






The anchoring of the PTDAs on graphene surface is also verified electrically by measuring the 
GFET transfer curves before and after the probe attachment. As shown in Figure 8.6A, the charge 
neutrality point shifts left upon PTDA immobilization on graphene. This negative shift is in 
accordance with the negative charges on the DNA backbone and the electron-rich pyrene group of 
the PTDA and is also consistent with the previous work by Wu et al [217]. Furthermore, the effects 
of an external electric field can also be characterized using the IDS-VGS curves. Figure 8.6A further 
shows that when a negative potential is applied at the gate, the PTDA immobilization efficiency 
is enhanced which is reflected by the increased amount of the negative shift in the charge neutrality 
point (VCNP) compared to the case without the external electric field. With a negative potential at 
the gate, the negatively charged single-stranded PTDAs tend to migrate towards graphene surface 
due to the electrostatic repulsion resulting in an increased density of the immobilized PTDA probes 
[223]. Figure 8.6B shows the bar graph indicating the amount of shift in the VCNP with respect to 
the blank GFET device for the two cases. With the electric field applied, the negative shift in the 
charge neutrality point was measured to be 123.53 mV which is approximately 2.5 times larger 
than that without the electric field. 
 
Figure 8.6. GFET transfer curves showing the effect of external electric field on functionalization 







8.3.1.4. Sensitivity and selectivity study of the sensor 
After the successful functionalization of the GFET with the PTDAs, the device was exposed to IL-
6 proteins to characterize its sensing performances. Prior to IL-6 exposure, in order to test the 
sensor’s selectivity to its target, the GFET-based IL-6 sensor was exposed to 100 nM of lysozyme 
protein (a model interfering species) in 0.01X PBS with 2 mM MgCl2 for 10 minutes. Once the 
selectivity of the IL-6 binding aptamers was confirmed, the sensor was then exposed to various 
concentrations (100 pM, 1 nM, 10 nM, and 100 nM) of the target protein (IL-6) in the same buffer 
and for the same exposure time. Figure 8.7A, B show the transfer curves and the bar graph, 
respectively, for each sample exposure. These results indicate that our sensor platform is minimally 
responsive to a non-target protein (lysozyme) even when a relatively large concentration (100 nM) 
is exposed. By contrast, upon introducing 100 pM of the target biomarker IL-6 to the GFET sensing 
area, the charge neutrality point shifts to the negative direction by a significant amount indicating 
the specific analyte recognition by the aptamers as well as the target selectivity of the developed 
IL-6 biosensor. The charge neutrality point continues to shift to the left with increasing 
concentrations of IL-6 (Figure 8.7C). This consistent negative shift can be attributed to the n-type 
doping of the graphene channel by the bound IL-6 proteins which have an isoelectric point of 4 ~ 
5.3 and therefore, is negatively charged under the buffer (pH=7.4) used in the experiment [224], 
[225]. The basis of this target-induced doping of graphene is the target-induced conformational 
change of the aptamers. In the absence of the target analytes, the aptamers anchored on the 
graphene surface are in an unfolded, loop and flexible state. Upon exposure of the IL-6 targets, 
target-induced conformational change of aptamers leads to a compact and stable state. These 
structural changes of aptamers brings the negatively charged IL-6 protein to the close proximity 
of the graphene surface, possibly resulting in a direct transfer (doping) of electrons from IL-6 to 
graphene due to the π-π stacking interactions between the aromatic amino acids in IL-6 and the 
basal plane of graphene [224]. 
 
Also, the specificity of sensor was examined by functionalizing the GFET with a random sequence 
aptamer using the same protocol as the IL-6 aptamer and exposing different concentrations of IL-
6 protein. The results are presented in Figure D3 (Appendix D) which shows negligible shift in the 





aptamer used in our sensor development exhibits specific target binding toward the IL-6 
biomarker. 
 
Figure 8.7. Sensing experiments with the GFET-based aptasensor: (A) the transfer curves, (B) the 
bar chart showing the selectivity of the sensor (error bar with n=3); (C) transfer curves of the GFET 
sensor when exposed to varying concentrations of IL-6; and (D) the concentration-dependent 
calibration curve (n=3).  
 
Figure 8.7D shows the calibration curve for a range of IL-6 concentrations obtained with a sample 
size of n = 3. The device-to-device variations were addressed by normalizing the sensor response 
(ΔVCNP) using the formula ΔVCNP/ΔVCNP,max, where VCNP,max is the charge neutrality 
point  corresponding to the maximum IL-6 concentration tested. The lowest concentration of 100 
pM was detected with this method. However, increasing the number of washings steps (with 70% 





lead to increased sensitivity. Moreover, adjusting the buffer pH to make IL-6 positively charged 
will increase the affinity between the positively charged IL-6 and negatively charged aptamer, 
possibly leading to enhanced sensitivity. As an example, Figure 8.8 shows the IL-6 sensing result 
and the corresponding calibration curve of the GFET-based biosensor in the same buffer (0.01x 
PBS + 2 mM MgCl2) but with the pH adjusted to ~3.64. 
 
Figure 8.8. Detection of IL-6 with the GFET-based biosensor under the pH of ~3.64: (A) IDS-VGS 
transfer curves for different concentrations of IL-6 protein and (B) the corresponding 
concentration-dependent calibration curve. The sample set is 𝑛 = 3 and error bar represents 1 
standard error. 
 
The limit of detection (LOD) of the GFET-based IL-6 sensor under this pH environment was 
calculated to be ~8 pM which is an order of magnitude larger than that under the physiological pH 
(pH ~7.4). Figure 8.8B also shows the Hill-Langmuir fit (See Appendix C) of the experimental 
data. The sensing performances of the proposed sensor are comparable to other results published 
in the literature. For example, Hao et al. have achieved a detection limit of 1.22 pM and a detection 
range of 1 pM–1 nM using conventional aptamer immobilization methods [223]. From the Hill-
Langmuir equation, the dissociation constant KD is estimated to be 3.4 nM, similar to the value 






8.4. Testing in Artificial Sweat 
To verify the applicability of the sensors in real samples, the sensors must be tested in real samples. 
As an initial step, the sensor was tested in diluted artificial perspiration (pH=7.4) purchased from 
Pickering Solutions. As the perspiration is highly viscous, it was first diluted 10 times using 0.01x 
PBS in 1mM MgCl2 and this diluted perspiration was spiked with different concentrations of IL-6 
protein which was exposed to the GFET sensor. The results are presented in Figure 8.9. With the 
Dirac voltage shifted consistently with increased concentration of IL-6 spiked in artificial 
perspiration, it is clear that the sensor is able to detect IL-6 in artificial sweat referring to its 
potential applicability in real human sweat.  
 
 
Figure 8.9. Detection of IL-6 in artificial perspiration. (A) GFET measurements showing relative 
shift for different concentrations of IL-6 spiked in diluted artificial perspiration, and (B) 
corresponding bar chart showing the shift of the Dirac voltage.  
8.5. Conclusion 
In this chapter, I develop a facile and rapid immobilization technique to attach target recognition 
probes on the GFET-based biosensing platform. The developed sensor is able to selectively 
measure IL-6 protein biomarker with the detection limit in the picomolar range. The sensitivity 
can be further improved by increasing the incubation time, purification steps as well as by adjusting 
the buffer pH to an acidic region. The proposed organic solvent-free aptamer immobilization 
technique is not only polymer friendly (and therefore allows more flexibility in device design and 





extra step needed for anchoring the linker molecules and the subsequent washing steps. I also 
demonstrate that an external electric field can be used to enhance the efficiency (~2.5 times) of the 
aptamer immobilization on the graphene surface. My proposed technology has the potential to be 






























 CONCLUSION AND FUTURE WORK 
8.1. Summary of Contributions  
The main contributions of this dissertation in the field of nanoelectronic device-based biosensors 
are briefly described as follows:  
A. The use of inkjet-printing in manufacturing low-cost electrochemical biosensors was 
presented (Chapter 4). Inkjet-printable ink based on CNT and aptamer mixture was 
prepared and printed on disposable screen-printed carbon electrode using drop-on-demand 
inkjet printer. We have shown that printing of CNT-based ink can be used as a means for 
immobilizing aptamers on the electrode contrary to the commonly used chemistries which 
are often time consuming, lacks control on packing density, as well require laboratory 
settings with trained personnel. The inkjet-printed biosensor not only addresses the issues 
in the conventional aptamer immobilization methods, but also demonstrates comparable 
performances with the conventional electrochemical biosensors in terms of sensitivity, 
selectivity, and shelf-life. 
B. A protein biomarker Lysozyme was detected using a CVD grown graphene FET for the 
first time (Chapter 5). The liquid-gated GFET device was able to selectively detect 
lysozyme with nanomolar limit of detection.  
C. An integrated GFET platform was developed to detect another protein biomarker Thrombin 
with picomolar limit of detection (Chapter 6). This was done by integrating the GFET 
device with microfluidic channel which eliminates the measurement inaccuracy introduced 
by evaporation and thus improves the sensitivity. Moreover, the compactness of the 
platform was enhanced by replacing the conventionally suspended gate electrode with an 
in-plane photolithographically-patterned gate electrode. Also, real-time continuous 
detection of Thrombin was demonstrated and verified with discreate measurements.  
D. A flexible GFET platform was developed using a PCB printed electrode on flexible 
polyimide (Kapton®) substrate. Graphene transfer protocol for the rigid SiO2/Si substrate 
was tailored considering the thermal and chemical stability of the flexible substrate. Real-
time detection of a sweat-based protein interleukin-6 (IL-6) was also demonstrated using 





E. The limitations of the conventionally manufactured electrode design were addressed by 
adopting a printing-based electrode fabrication method (Chapter 7). Conventionally, 
electrodes are manufactured using microfabrication techniques which require costly 
microfabrication setup, sophisticated cleanroom environment as well as trained personnel 
limiting the affordability of the sensors in point-of-care applications. However, the 
proposed device electrodes printed with a benchtop PCB printer not only addresses the 
above-mentioned issues but is also compatible with applications requiring flexible 
substrates. This enables the development of a wearable biosensor for real-time continuous 
monitoring of individual’s health. 
F. A facile and rapid aptamer-immobilization method was developed for functionalizing 
GFET devices without the need of any organic solvents such as dimethyl formamide 
(DMF) or Dimethyl siloxane (DMSO). These organic solvents often used in the 
conventional aptamer immobilization method on GFET are generally not compatible with 
the polymer-based substrates as well as the fluidic tubings and channels for flexible and 
lab-on-a-chip based sensing devices. Therefore, this organic solvent-free immobilization 
method can address these challenges by eliminating the use of such organic solvents 
(Chapter 8).  
G. The effects of various gate materials (Pt, Au, Ag/AgCl) on the GFET measurements were 
investigated. It is found that among the three gates, Ag/AgCl demonstrates the best 
performance in terms of operating voltage, gate leakage and gate hysteresis, while in-plane 
gold electrode results in the most stable charge neutrality point (Chapter 8). 
 
8.2. Future Work  
The sensors developed in this work has great potentials for health care monitoring, especially for 
point-of-care diagnostics and personalized medicine. However, before field deployment of these 
devices can become a reality, certain challenges still remain to be addressed. The following are the 
future research directions needed in order to render these sensing platforms field deployable.  
 
8.2.1. Real-sample analysis 
Though novel contributions have been made towards developing nanoelectronic device-based 





Though the sensors passed the selectivity test performed by adding a limited number of interferants 
into the buffer, real-sample analysis is of paramount importance to make sure that the developed 
sensors function properly with human samples such as serum, saliva, etc. as real human samples 
contain thousands of interferants that could reduce the signal-to-noise ratio (SNR).  The sensors 
should be equipped with interferant-rejecting mechanisms such as coating materials or blocking 
agents [226] that could prevent non-specific adsorption (NSA) leading to an increase in the 
sensor’s inertness to non-target interferants. For example, Wang et al. employed a polymer coating, 
namely polyethylene glycol (PEG), to functionalize GFET surface for preventing NSA for 
aptamer-based detection of IgE protein in human serum [91]. However, the PEG modified GFETs 
experienced significant reduction in the transconductance [227], thus negatively affecting the 
sensitivity. Therefore, novel NSA reduction methods without affecting sensing performances 
should be developed. 
 
8.2.2. Flexible printed GFET 
Though printed Kapton® GFET has been shown to be effective for real-time sensing of IL-6 
biomarkers. Possible modifications for improving the performance of the printed GFET are 
discussed in this section.  
 
Choosing the right flexible substrate could be one future direction of research for improving the 
performance of the flexible GFET. Though Kapton® stands out as one of the best flexible substrate 
in terms of their chemical and thermal stability to tolerate the heating steps in the manufacturing 
processes, there are a few drawbacks associated with this material. One of them is the poor 
adhesion of the printed electrodes that causes the electrodes to peel off from the substrate.  Though 
high temperature sintering can address the issue to some extent, it might affect the substrate’s 
thermal stability. Therefore, other polymer materials should be investigated to solve this issue. For 
example, Liang et al. used polyethylene naphthalate (PEN) substrate (Teonex® Q65 film) for 
developing a flexible GFET [228].  In another example, Mylar was used for developing a flexible 
and stretchable GFET for detection of TNF-α [194]. The decreased carrier mobility due to the 
unwanted doping induced in graphene by the flexible substrates should also be considered. This 






Another area for improvement in the printed GFET of this work is the lack of stretchability due to 
the cracking of the printed electrodes. Therefore, development of a highly conductive and 
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A.1. Calculation of Printed Volume of CNT-Aptamer Ink 
Number of droplets printed on a 4 mm length = 
4.0 mm
20×10−3 mm
 = 200 
Total number (#) of droplets in the 4 mm square = (200)2 = 40,000 
# of droplets in the 4mm diameter circular electrode = 
πr2
d2




Hence, the amount of ink per layer printed on the electrode = 31416 × 10 pL = 0.31416 µL ≈
315 nL.  
 
A.2. Lysozyme Binding Confirmation 
To confirm that lysozyme binds to the aptamer, we performed lysozyme binding experiments with 
MB-labelled thiolated DNA aptamers on gold rod electrode. The electrochemical DNA-based 
lysozyme sensor was fabricated on a 3 mm gold rod electrode (A-002421, Bio-Logic USA Science 
Instruments, TN, USA) using a previously described method [244]. The experiments were 
performed using Ag/AgCl as the reference electrode and platinum as the counter electrode. The 
results are presented in Figure A2. 
  
(a) (b) 
Figure A2. Square wave voltammograms obtained for different concentrations of lysozyme in 
10 mM PBS buffer. 
 
It can be seen that, when lysozyme is exposed to the aptamer-modified gold electrode, the peak 
current reduces until it reaches saturation for higher concentration of lysozyme. These results 






In the absence of lysozyme, the MB-labelled aptamer probes are relatively flexible; allowing the 
attached MB to collide with the electrode that enables efficient electron transfer from the MB to 
the electrode. This is in accordance with the relatively high voltammetric peak current for the 
reversible reduction of MB as characterized using square wave voltammetry (SWV). When 
lysozyme binds to the aptamer due to the specific affinity, the aptamer undergoes conformational 
change that alters the electron tunneling distance hindering the charge transfer from the MB to the 
electrode. As a result, the voltametric peak current decreases. 
 
A.3. Chronocoulometric Experiments 
To perform chronoloculometry, the printed sensor was incubated in 1mM RuHex in 10 mM Tris-
HCl solution for 1 h. During the incubation, RuHex ions electrostatically bind to the negative 
backbones of the DNA aptamers. The number of probe molecules are thus proportional to the 
number of bound RuHex ions to the DNA probes. After RuHex incubation, the electrode is then 
washed thoroughly in DI water to remove the unbound RuHex ions. 
 
We first characterized the redox reaction of RuHex at the printed electrode using cyclic 
voltammetry (CV). The CV curves are presented in Figure A3(a) before and after the RuHex 
incubation. The two CV peaks with almost zero peak separation in the presence of RuHex indicates 
the electrostatically bound RuHex ions to the backbones of the surface-confined DNAs [247]. 
Figure A3(b) displays the CC curves at the printed electrode in the presence and absence of 1 mM 
RuHex. QSE is obtained from the CC intercepts at t = 0 and the surface density of probe DNAs can 







Figure A3. (a) Cyclic voltammograms (scan rate: 500 mV/s); and (b) CC responses curves of 
printed electrode in the presence (red) and absence (black) of RuHex. 
A.4. LOD Calculation 
The limit of detection (LOD) can be calculated by the following equation [248]: 
 
𝐿𝑜𝐷 =
3.3 × 𝑆𝑡𝑎𝑏𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 0
𝜇𝑔
𝑚𝐿 𝐿𝑦𝑠 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛







= 90.4 ng/mL 
A.5. Effect of number of printed layers on sensor responses  
 
Figure A4. Comparison of the sensor responses as a function of the different printing layers. 














B.1. Lysozyme Binding Confirmation 
Lysozyme binding to the aptamers was confirmed by performing experiments with methylene blue 
(MB)-labelled thiolated DNA aptamers (LGC Biosearch Technologies, CA, USA) with the same 
sequence as used by Ellington et al. [122] on gold rod electrode. The DNA-based electrochemical 
lysozyme sensor was fabricated on a gold rod electrode (A-002421, Bio-Logic USA Science 
Instruments, TN, USA) of 3 mm diameter using a previously described method [244]. The 
experiments were performed in a 3-electrode electrochemical cell with Ag/AgCl as the reference 
electrode and platinum as the counter electrode. The results are presented in Figure B1.  
 
Figure B1. Square wave voltammograms obtained for different concentrations of lysozyme in 
0.01X PBS.  
 
It can be seen from Supplementary Figure B1 that the peak current reduces when lysozyme is 
exposed to the aptamer-modified gold electrode which suggests that specific binding of lysozyme 
to the aptamer-based recognition element has occurred [245], [246]. In the absence of lysozyme, 
the MB-labels are easily accessible to the electrode which enables efficient electron transfer 
between the MB and the electrode. This causes high voltammetric peak current for the reduction 
of MB as characterized using square wave voltammetry (SWV). When lysozyme comes in 





to capture the proteins. This alters the electron tunneling distance hindering the charge transfer 












































C.1. Device Fabrication 
C.1.1. Graphene transfer 
To transfer graphene onto the substrate, the monolayer graphene on polymer film was immersed 
in deionized water slowly while the graphene film protected by the sacrificial layer was detached 
from the support polymer film and remained floating on the water.  The floating sacrificial 
layer/graphene layer was then collected by the patterned gold electrode substrate which was then 
dried at room temperature for 30 minutes followed by annealing on hot plate at 150 C for 1 hour. 
To remove the top sacrificial layer, the sample was then treated with acetone for 1 hour followed 
by dipping into ethanol for another 1 hour. Finally, the sample was dried with an air gun and 
thermally annealed in an oven at 300 C in argon atmosphere for 2 hours.  
C.1.2. Microfluidic channel fabrication 
The microfluidic channel was fabricated with a PDMS block using the cast molding technique 
[180]. For this, an SU-8 (MicroChem Corp.) master mold with the desired channel pattern (width: 
600 µm, height: 100 µm) was formed on silicon wafer surface. The degassed mixture of PDMS 
prepolymer and curing agent (Sylgard 184) mixed at a weight ratio of 10:1 was poured on the 
prepared master mold. Then the PDMS block was cured at 60 C for 4 hours and then peeled off 
from the SU-8 mold.  
 
C.2. GFET Devices Labels 
Table C1: Summary of the labels for the 6 GFET devices in the microfluidic-integrated GFET 
device. 


























C.3. Aptamer Packing Density Estimation 
The change of surface charge (ΔQ) can be expressed as [197],  
∆𝑄 = 𝐶 × ∆𝑉𝐷                                                                   (1) 
Where, ∆𝑉𝐷 is the shift in Dirac voltage, and 𝐶 is the total gate capacitance, which can be 












                                                            (2) 
Where, 𝐶𝐺1 and, 𝐶𝐺2 are the geometrical capacitances formed due to the electrical double layer 
capacitances on different interfaces and denote the capacitance between the graphene and solution, 
and the capacitance between the gate electrode and solution, respectively. 𝑑1 and 𝑑2 represent the 
plate distances for  𝐶𝐺1 and 𝐶𝐺2, respectively where 𝑑1 = 𝑑2 = 𝑑 = Debye length.  𝐶𝑄 which is 
related to the Fermi level shift, denotes the quantum capacitance of graphene associated with finite 
density of states due to Pauli principle [230].  
 









where, Sgraphene is the contact area between the electrolyte and graphene monolayer, Sgate is the 
contact area between the electrolyte and gold gate electrode, 𝜀0 is the vacuum permittivity 
(8.854 × 10−12 𝐹/𝑚) and 𝜀𝑟  is the relative dielectric constant of PBS solution (80). Estimated 
Debye length for a 0.01× PBS buffer concentration, 𝑑 =  7.3 𝑛𝑚.  
 





𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 = 𝐿𝑔𝑓 × 𝑊𝑚𝑐  
where, Lgf is length of the graphene film which equals to 5 mm or 5000 µm and Wmc is the width 
of the microfluidic channel that equals to 600 µm. Therefore,  
𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 =  3,000,000 µ𝑚
2. 
Similarly, Sgate can be expressed as: 
𝑆𝑔𝑎𝑡𝑒 = 𝐿𝑔𝑎𝑡𝑒 × 𝑊𝑚𝑐 
where, Lgate is the width of each gate electrode which equals to 100 µm and Wmc is the width of 
the microfluidic channel that equals to 600 µm. Therefore,  
Sgate= 100×600 =60,000 µm2. 
 














= 5.822 nF  
The total geometrical capacitance (CTG) can be calculated as the series combination of 𝐶𝐺1 and 𝐶𝐺2 
and the value yields, 𝐶𝑇𝐺 = 57.08 𝑛𝐹.  
 
The quantum capacitance CQ can be expressed as:  
𝐶𝑄 = 𝐶𝑞×𝑆𝑔𝑟𝑎𝑝ℎ𝑒𝑛𝑒 
where Cq is the quantum capacitance per unit area and the value is ~ 2 µF/cm
2 [197] . Therefore, 
𝐶𝑄 = 0.6 nF. 
 
Now, the total gate capacitance, C can be calculated from Equation (2) as: C= 0.593 nF. 
 
From Figure 6.3D, the attachment of 27-mer thrombin-binding aptamer leads to a Dirac voltage 
shift, ΔVDirac= 403.9 mV.  
So, ∆𝑄 = 𝐶 × ∆𝑉𝐷 =  0.593 × 10
−9 × 403.9 × 10−3 =  2.4 × 10−10 C. 
 
If the probe density is 𝑛, ∆𝑄 can be written as:  











=1.85 × 1013/𝑚2= 1.85 × 109/𝑐𝑚2. 
Therefore, the aptamer probe density can be estimated to be 1.85 × 109/𝑐𝑚2. This is equivalent 
to 232 nm aptamer probe spacing which is comparable to other reported values in literature [154].  
 
C.4. Control Experiments 
To examine the inertness of the bare graphene to thrombin, a set of control experiments were 
performed by exposing bare graphene to thrombin solution of various concentrations. The 
measured transfer curves are presented in Figure C1. It can be seen that there is no significant shift 
in the Dirac voltage, indicating non-responsive behavior of bare unmodified graphene to thrombin.   
 
Figure C1: Control experiments. ID-VGS transfer curves of (A) bare graphene, and (B) lysozyme 
(LYS) aptamer modified graphene exposed to different concentrations (from 1 pM to 1 µM) of 
thrombin.  
 
C.5. Calculation of Limit of Detection (LOD)  
Limit of detection can be calculated according to the following equation:  
𝐿𝑂𝐷 =
3.3 × 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑 𝑑𝑒𝑣𝑖𝑎𝑡𝑖𝑜𝑛 𝑎𝑡 𝑡ℎ𝑒 𝑙𝑜𝑤𝑒𝑠𝑡 𝑐𝑜𝑛𝑐𝑒𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑑
𝑆𝑙𝑜𝑝𝑒 𝑜𝑓 𝑡ℎ𝑒 𝑐𝑎𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 𝑐𝑢𝑟𝑣𝑒
 
   = 
3.3×11.8521
14.8715
 =2.63 pM  







Figure C2. Calculation of transconductance 
C.7. Current Calibration Curve from Transient Measurements 
 
Figure C3. The concentration-dependent drain current (ID) calibration plot and its Hill-Langmuir 
fit curve (R2 = 97.78%). 

















Table C2 summarizes the best fit (𝑅2=0.9778) values of the Hill-Langmuir equation.  It gives a 
dissociation constant of 𝐾𝐷 = 0.7317 nM which is comparable to the value obtained from the 
voltage calibration curve. 
 
Table C2. Summary of the Hill Langmuir fitting parameters of the current calibration curve in 


































D.1. Confirmation of the presence of DNA nucleobases in the synthesized product 
 
 
Figure D1. UV-visible spectrum of the pyrene tagged DNA aptamer. The peak at 260 nm is the 
characteristic DNA peak that corresponds to the presence of DNA nucleobases in the synthesized 
product.  
 





Figure D2. Measurement data for a gate (Pt) electrode: (A) gate leakage (IGS) vs gate-source 
voltage (VGS), and (B) IDS-VGS transfer curve showing the amount of hysteresis (ΔVCNP,h). 





D3. Hill-Langmuir fitting of aptamer-protein equilibrium binding  
The calibration curve profile presented in Figure 8.8 can be best modeled by the Hill-Langmuir 
equation that describes the equilibrium binding of a ligand by a receptor [231]–[233]: 
𝑟 =










where 𝑟0 represents the estimated minimum response while all the binding sites are empty, 𝑟𝑚 is 
the estimated maximum response while the binding sites are occupied, 𝑐 indicates the target 
concentration, 𝐾𝐷 is the effective dissociation constant which is defined as the concentration where 
half of the available binding sites are occupied, and 𝑛 represents the Hill coefficient.  
  
Table 1 summarizes the values of the parameters that result in the best fit (R2 = 0.9925) for the 
Hill-Langmuir model of the calibration curve. A Hill coefficient value of n = 0.3 (which should be 
close to 1 under ideal conditions) indicates a decreased binding affinity with the target which may 
be caused by the interactions among the neighboring proteins or by the increased charge carrier 
scattering as more ligand bindings occur on the graphene surface [137], [234]. The best fit value 
of KD = 3.4 ± 2 nM is nearly identical to the value reported by the aptamer manufacturer. Based 
on the obtained calibration curve, the limit of detection (LOD) of our sensor is calculated to be ~8 
pM.  
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To test the specificity of the GFET sensor, the GFET was functionalized with a randomized 
aptamer sequence using the same one-step functionalization protocol as the IL-6 aptamer. The 
sequence of the randomized single-stranded DNA was: 
ATCAGGGCTAAAGAGTGCAGAGTTACTTAG. Following functionalization, the aptamer 
modified GFET was exposed to different concentrations (1, 10 and 100 nM) of IL-6 protein. The 
results are presented in Figure D3, which shows no significant shift of the charge neutrality point 
upon exposure of the IL-6 protein. This is due to the fact that the random sequence aptamer does 
not exhibit high affinity toward IL-6 protein suggesting the specificity of our sensor toward the 
target protein IL-6.  
 
Figure D3: Scramble aptamer test: (A) GFET measurements of the scramble aptamer modified 
GFET upon exposure of different concentrations of IL-6 protein, and (B) Comparative bar chart 
showing the response of IL-6 protein to the aptamer-modified GFET. 
 
 
